Probiotic Strains Market by Type (Lactobacillus (Lactobacillus Acidophilus, Lactobacillus Rhamnosus GG (LGG), Others) Bifidobacterium (Bifidobacterium Bifidum, Bifidobacterium Breve, Bifidobacterium Animalis, Others) Saccharomyces, Streptococcus, Enterococcus, Escherichia, Bacillus, Others) by Formulation (Single Strains, Multi Strains) by Product Form (Powder, Capsules, Liquids, Lozenges, Others) by Health Indication (Digestive Health, Weight Management, Immune Health, Women’s Health, Heart Health, Oral Health, Colon Health, Bone Health, GI Tract Health, Others) by Application (Food & Beverage (Bakery, Dairy, Beverages, Others) Nutritional & Dietary Supplements, Animal Feed, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2020 - 2028
Industry Trends
Global probiotic strains market is expected to reach US$ 65.92 billion by 2028, growing at a CAGR of 5.1% over the forecast period. Gut health has shown to be the world's primary field for functional foods. These products are described by the World Health Organization (WHO) as live microorganisms that give the host a health benefit when administered in sufficient quantities. To be classified as probiotic the manufacturer must document scientific evidence of the health benefit to regulatory authorities such as the FDA or the European Commission. As they prevent the development of diseases by improving the immune system they play an important role in preventive healthcare. The rising demand has also shown that clients prefer goods with proven advantages. When eaten in appropriate quantities, probiotics have beneficial effects on the human body, such as increased gut health and decreased inflammation of the intestines. In preventive healthcare probiotics play a major role as they prevent the development of diseases by improving the immunity. Therefore the overall market growth over is projected to benefit from growing understanding of preventive healthcare products.
A safe lifestyle and food decisions that help avoid the incidence of diseases are part of preventive healthcare. Due to numerous factors such as growing disposable income, living standards, and growth in the number of the elderly population understanding of preventive healthcare is increasing. Probiotics are live microbial bacteria that are used in human and animal diet supplements as they improve the immune system and aid digestion quickly and efficiently. By aiding the development of digestive enzymes and triggering the production of healthy gut bacteria probiotics also help to improve tolerance against viruses, microbes and bacteria. They are compatible with multiple food applications such as bakery and dairy products. Probiotic strains are commonly used to improve drinks as they help preserve the balance of salt and decrease dehydration by controlling the flow of digestive juices. Regular ingestion of probiotic-induced drinks keeps the stomach, intestines clean thereby allowing vital nutrients to be properly digested and reducing symptoms of acid reflux which could improve the consumer outlook for probiotics.
The use of probiotic strains in fermented meat products such as salami and ham increases the elasticity of the dough, making the breakdown of complex protein simpler for stomach acids and promoting digestion. By providing natural protection against airborne mold and bacteria probiotics help to improve the shelf life of meat products thus reducing the risk of cross contamination. With growing demand in different industries the use of probiotics has gained popularity in recent years. The major driving factors for the growth of the global probiotics market are the emphasis on improving digestive health in humans and animals along with growing demand for natural functional ingredients. The demand for probiotics has been boosted by rising consumer understanding of the benefits of probiotics and preventive healthcare thus propelling market growth. During the forecast era, the global demand for probiotics is expected to record significant growth. As eating habits as well as food preferences have been influenced by hectic daily schedules, long working hours and sedentary lifestyles resulted an increase in prevalence of different lifestyle-related disorders such as diabetes and obesity. This has resulted in increased demand for food & beverages from probiotics.
In addition, the increasing demand for probiotics in developed and developing countries is driving the growth of the market. Product innovation and research and development have also contributed to new growth opportunities for manufacturers of probiotics. Proof of benefits associated with probiotics for health restoration has increased consumer expectations for health-care functions linked to probiotics. The application of products as pharmaceutical agents has contributed to a tendency towards natural, safe, and cost-effective alternative for drugs. Clinical trials have shown that specific diseases or disorders in humans especially those linked to the gastrointestinal tract can be cured. However, it is anticipated that significant investments in R&D activities and investments in testing facilities, laboratories and the high cost of recruiting skilled professionals would build barriers to market development. Owing to the high intensity of competition from the pharmaceutical, biotechnological and food and beverage industries to develop their presence in the market products with health benefits are making it difficult for probiotic industry players to achieve a satisfactory return on investment. Probiotic strains and products are produced and manufactured in compliance with the United Nations Food and Agriculture Organization (FAO) and WHO international food regulations. Marketing of these goods often adds to the price of the product because as opposed to traditional products, they need different packaging and distribution channels.
Industry players have launched new products in the market to gain a competitive advantage over other companies. Different types of products such as probiotic drops, tablets, and capsules containing various probiotic strains are available in the market. The adoption of probiotic supplements has increased in many countries due to increasing health awareness among the people.
Type Insights
The work undertaken by research institutes to develop different strains that help to improve the probiotic properties of beverages has resulted in a wide spread use of these strains. Strains that include Lactobacillus casei Immunitas are found to be used by users in different regions. The supply and demand-side variables are expected to help companies invest in strain research and develop optimised line-up goods.
Formulation Insights
In formulation the single strain segment will have a highest market share over the forecast period. When shopping for probiotic products both single strain and multi strain products are available widely. Due to low cost and dosage size the adoption of single strain products is more prominent among the consumers.
Product Form Insights
Due to its application in yogurt, which is the most popular source of probiotics, the demand for liquid probiotics has increased compared to dry probiotics. Kefir water, probiotic juices and yogurt-based drinks which are healthy options for daily supplementation are other products that use liquid probiotics.
Health Indication Insights
Due to increasing efforts of different organisations to increase awareness among the general population for different medical conditions the adoption of preventive care has grown over the years. Similar trends are seen in the market for probiotic strains as well. Over the years, major users of probiotic products are people suffering from conditions such as digestive system disorders, intolerance to certain substances, or allergies. In addition, increasing awareness of immunity boosters in the wake of the novel coronavirus is leading users to adopt probiotic products. Demand for immunity booster’s products is expected to grow in the near future.
Application Insights
The food & beverages segment is estimated to account for the largest share of the probiotics strains market. The products in this category because of their specific ingredients offer distinct health benefits beyond basic nutrition. The food & beverage segment is the biggest region-wide revenue-earning market. In order to increase the overall nutritional value as well as the flavour of the baked products, probiotics are incorporated. The consumption of these baked products infused with probiotics has increased in recent years due to an increasing inclination towards preventive healthcare.
Regional Insights
Asia Pacific is a lucrative market for probiotic strains. The adoption of these products has increased due to increasing health awareness among the general population. Over the forecast period, North America is also expected to witness significant growth. It is anticipated that ongoing investments from producers will contribute to the growth of the market. Regional players are investing in research and development to develop products to cater to consumers of various age groups and genders.
Probiotic Strains Market Revenue & Forecast, (US$ Million), 2020 – 2028
Competitive Landscape
The report provides both, qualitative and quantitative research probiotic strains market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
The major players operating in the market include Aumgene Biosciences, BioGaia, BLIS Technologies., Cerbios-Pharma SA, Chr. Hansen Holding A/S, DSM, DuPont, Essum AB, Kerry Inc., Lab4, Lallemand Inc., Phileo by Lesaffre., Probi, Protexin, Unique Biotech and other market participants.
Probiotic Strains Market:
- By Type
- Lactobacillus
- Lactobacillus Acidophilus
- Lactobacillus Rhamnosus GG (LGG)
- Others
- Bifidobacterium
- Bifidobacterium Bifidum
- Bifidobacterium Breve
- Bifidobacterium Animalis
- Others
- Saccharomyces
- Streptococcus
- Enterococcus
- Escherichia
- Bacillus
- Others
- Lactobacillus
- By Formulation
- Single Stains
- Multi Strains
- By Product Form
- Powder
- Capsules
- Liquids
- Lozenges
- Others
- By Health Indication
- Digestive Health
- Weight Management
- Immune Health
- Women’s Health
- Heart Health
- Oral Health
- Colon Health
- Bone Health
- GI Tract Health
- Others
- By Application
- Food & Beverage
- Bakery
- Dairy
- Beverages
- Others
- Nutritional & Dietary Supplements
- Animal Feed
- Others
- Food & Beverage
- By Geography
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2018
1.2.2. Base
Year: 2019
1.2.3. Forecast
Years: 2020 – 2028
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Probiotic Strains Market
6. Market
Synopsis: Probiotic Strains Market
7. Probiotic
Strains Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Probiotic Strains Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Probiotic Strains Market
7.6. Porter’s Five Force Analysis
7.7. Impact of
Covid-19 on Probiotic Strains Market
8. Global
Probiotic Strains Market Analysis and Forecasts, 2020 – 2028
8.1. Overview
8.1.1. Global
Probiotic Strains Market Revenue (US$ Mn)
8.2. Global
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1. Lactobacillus
(Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation
(2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Lactobacillus Acidophilus,
Lactobacillus Rhamnosus GG (LGG), Others)
8.2.1.1. Lactobacillus
Acidophilus
8.2.1.2. Lactobacillus
Rhamnosus GG (LGG)
8.2.1.3. Others
8.2.2. Bifidobacterium
(Definition, Market Estimation and Penetration, 2015 – 2019, Market Estimation
(2015 – 2019), Market Forecast (2020 – 2028), Compound Annual Growth Rate (CAGR),
Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and
Africa, Latin America) and Information on Bifidobacterium Bifidum,
Bifidobacterium Breve, Bifidobacterium Animalis, Others)
8.2.2.1. Bifidobacterium
Bifidum
8.2.2.2. Bifidobacterium
Breve
8.2.2.3. Bifidobacterium
Animalis
8.2.2.4. Others
8.2.3. Saccharomyces
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2019
8.2.3.3. Market
Forecast, 2020 – 2028
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2019
8.2.3.5.1.2. Market
Forecast, 2020 – 2028
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2019
8.2.3.5.2.2. Market
Forecast, 2020 – 2028
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2019
8.2.3.5.3.2. Market
Forecast, 2020 – 2028
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2019
8.2.3.5.4.2. Market
Forecast, 2020 – 2028
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2019
8.2.3.5.5.2. Market
Forecast, 2020 – 2028
8.2.4. Streptococcus
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 – 2019
8.2.4.3. Market
Forecast, 2020 – 2028
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 – 2019
8.2.4.5.1.2. Market
Forecast, 2020 – 2028
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 – 2019
8.2.4.5.2.2. Market
Forecast, 2020 – 2028
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 – 2019
8.2.4.5.3.2. Market
Forecast, 2020 – 2028
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 – 2019
8.2.4.5.4.2. Market
Forecast, 2020 – 2028
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 – 2019
8.2.4.5.5.2. Market
Forecast, 2020 – 2028
8.2.5. Enterococcus
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 – 2019
8.2.5.3. Market
Forecast, 2020 – 2028
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 – 2019
8.2.5.5.1.2. Market
Forecast, 2020 – 2028
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 – 2019
8.2.5.5.2.2. Market
Forecast, 2020 – 2028
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 – 2019
8.2.5.5.3.2. Market
Forecast, 2020 – 2028
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 – 2019
8.2.5.5.4.2. Market
Forecast, 2020 – 2028
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 – 2019
8.2.5.5.5.2. Market
Forecast, 2020 – 2028
8.2.6. Escherichia
8.2.6.1. Definition
8.2.6.2. Market
Estimation and Penetration, 2015 – 2019
8.2.6.3. Market
Forecast, 2020 – 2028
8.2.6.4. Compound
Annual Growth Rate (CAGR)
8.2.6.5. Regional
Bifurcation
8.2.6.5.1. North
America
8.2.6.5.1.1. Market
Estimation, 2015 – 2019
8.2.6.5.1.2. Market
Forecast, 2020 – 2028
8.2.6.5.2. Europe
8.2.6.5.2.1. Market
Estimation, 2015 – 2019
8.2.6.5.2.2. Market
Forecast, 2020 – 2028
8.2.6.5.3. Asia
Pacific
8.2.6.5.3.1. Market
Estimation, 2015 – 2019
8.2.6.5.3.2. Market
Forecast, 2020 – 2028
8.2.6.5.4. Middle
East and Africa
8.2.6.5.4.1. Market
Estimation, 2015 – 2019
8.2.6.5.4.2. Market
Forecast, 2020 – 2028
8.2.6.5.5. Latin
America
8.2.6.5.5.1. Market
Estimation, 2015 – 2019
8.2.6.5.5.2. Market
Forecast, 2020 – 2028
8.2.7. Bacillus
8.2.7.1. Definition
8.2.7.2. Market
Estimation and Penetration, 2015 – 2019
8.2.7.3. Market
Forecast, 2020 – 2028
8.2.7.4. Compound
Annual Growth Rate (CAGR)
8.2.7.5. Regional
Bifurcation
8.2.7.5.1. North
America
8.2.7.5.1.1. Market
Estimation, 2015 – 2019
8.2.7.5.1.2. Market
Forecast, 2020 – 2028
8.2.7.5.2. Europe
8.2.7.5.2.1. Market
Estimation, 2015 – 2019
8.2.7.5.2.2. Market
Forecast, 2020 – 2028
8.2.7.5.3. Asia
Pacific
8.2.7.5.3.1. Market
Estimation, 2015 – 2019
8.2.7.5.3.2. Market
Forecast, 2020 – 2028
8.2.7.5.4. Middle
East and Africa
8.2.7.5.4.1. Market
Estimation, 2015 – 2019
8.2.7.5.4.2. Market
Forecast, 2020 – 2028
8.2.7.5.5. Latin
America
8.2.7.5.5.1. Market
Estimation, 2015 – 2019
8.2.7.5.5.2. Market
Forecast, 2020 – 2028
8.2.8. Others
8.2.8.1. Definition
8.2.8.2. Market
Estimation and Penetration, 2015 – 2019
8.2.8.3. Market
Forecast, 2020 – 2028
8.2.8.4. Compound
Annual Growth Rate (CAGR)
8.2.8.5. Regional
Bifurcation
8.2.8.5.1. North
America
8.2.8.5.1.1. Market
Estimation, 2015 – 2019
8.2.8.5.1.2. Market
Forecast, 2020 – 2028
8.2.8.5.2. Europe
8.2.8.5.2.1. Market
Estimation, 2015 – 2019
8.2.8.5.2.2. Market
Forecast, 2020 – 2028
8.2.8.5.3. Asia
Pacific
8.2.8.5.3.1. Market
Estimation, 2015 – 2019
8.2.8.5.3.2. Market
Forecast, 2020 – 2028
8.2.8.5.4. Middle
East and Africa
8.2.8.5.4.1. Market
Estimation, 2015 – 2019
8.2.8.5.4.2. Market
Forecast, 2020 – 2028
8.2.8.5.5. Latin
America
8.2.8.5.5.1. Market
Estimation, 2015 – 2019
8.2.8.5.5.2. Market
Forecast, 2020 – 2028
8.3. Key
Segment for Channeling Investments
8.3.1. By Type
9. Global
Probiotic Strains Market Analysis and Forecasts, 2020 – 2028
9.1. Overview
9.2. Global
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
9.2.1. Single
Stains
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2019
9.2.1.3. Market
Forecast, 2020 – 2028
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2019
9.2.1.5.1.2. Market
Forecast, 2020 – 2028
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2019
9.2.1.5.2.2. Market
Forecast, 2020 – 2028
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2019
9.2.1.5.3.2. Market
Forecast, 2020 – 2028
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2019
9.2.1.5.4.2. Market
Forecast, 2020 – 2028
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2019
9.2.1.5.5.2. Market
Forecast, 2020 – 2028
9.2.2. Multi
Strains
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 – 2019
9.2.2.3. Market
Forecast, 2020 – 2028
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market
Estimation, 2015 – 2019
9.2.2.5.1.2. Market
Forecast, 2020 – 2028
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 – 2019
9.2.2.5.2.2. Market
Forecast, 2020 – 2028
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market
Estimation, 2015 – 2019
9.2.2.5.3.2. Market
Forecast, 2020 – 2028
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 – 2019
9.2.2.5.4.2. Market
Forecast, 2020 – 2028
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market
Estimation, 2015 – 2019
9.2.2.5.5.2. Market
Forecast, 2020 – 2028
9.3. Key
Segment for Channeling Investments
9.3.1. By
Formulation
10. Global
Probiotic Strains Market Analysis and Forecasts, 2020 – 2028
10.1. Overview
10.2. Global
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
10.2.1. Powder
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2019
10.2.1.3. Market
Forecast, 2020 – 2028
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2019
10.2.1.5.1.2. Market
Forecast, 2020 – 2028
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2019
10.2.1.5.2.2. Market
Forecast, 2020 – 2028
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2019
10.2.1.5.3.2. Market
Forecast, 2020 – 2028
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2019
10.2.1.5.4.2. Market
Forecast, 2020 – 2028
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2019
10.2.1.5.5.2. Market
Forecast, 2020 – 2028
10.2.2. Capsules
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2019
10.2.2.3. Market
Forecast, 2020 – 2028
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2019
10.2.2.5.1.2. Market
Forecast, 2020 – 2028
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2019
10.2.2.5.2.2. Market
Forecast, 2020 – 2028
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2019
10.2.2.5.3.2. Market
Forecast, 2020 – 2028
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2019
10.2.2.5.4.2. Market
Forecast, 2020 – 2028
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2019
10.2.2.5.5.2. Market
Forecast, 2020 – 2028
10.2.3. Liquids
10.2.3.1. Definition
10.2.3.2. Market
Estimation and Penetration, 2015 – 2019
10.2.3.3. Market
Forecast, 2020 – 2028
10.2.3.4. Compound
Annual Growth Rate (CAGR)
10.2.3.5. Regional
Bifurcation
10.2.3.5.1. North
America
10.2.3.5.1.1. Market
Estimation, 2015 – 2019
10.2.3.5.1.2. Market
Forecast, 2020 – 2028
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 – 2019
10.2.3.5.2.2. Market
Forecast, 2020 – 2028
10.2.3.5.3. Asia
Pacific
10.2.3.5.3.1. Market
Estimation, 2015 – 2019
10.2.3.5.3.2. Market
Forecast, 2020 – 2028
10.2.3.5.4. Middle
East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 – 2019
10.2.3.5.4.2. Market
Forecast, 2020 – 2028
10.2.3.5.5. Latin
America
10.2.3.5.5.1. Market
Estimation, 2015 – 2019
10.2.3.5.5.2. Market
Forecast, 2020 – 2028
10.2.4. Lozenges
10.2.4.1. Definition
10.2.4.2. Market
Estimation and Penetration, 2015 – 2019
10.2.4.3. Market
Forecast, 2020 – 2028
10.2.4.4. Compound
Annual Growth Rate (CAGR)
10.2.4.5. Regional
Bifurcation
10.2.4.5.1. North
America
10.2.4.5.1.1. Market
Estimation, 2015 – 2019
10.2.4.5.1.2. Market
Forecast, 2020 – 2028
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 – 2019
10.2.4.5.2.2. Market
Forecast, 2020 – 2028
10.2.4.5.3. Asia
Pacific
10.2.4.5.3.1. Market
Estimation, 2015 – 2019
10.2.4.5.3.2. Market
Forecast, 2020 – 2028
10.2.4.5.4. Middle
East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 – 2019
10.2.4.5.4.2. Market
Forecast, 2020 – 2028
10.2.4.5.5. Latin
America
10.2.4.5.5.1. Market
Estimation, 2015 – 2019
10.2.4.5.5.2. Market
Forecast, 2020 – 2028
10.2.5. Others
10.2.5.1. Definition
10.2.5.2. Market
Estimation and Penetration, 2015 – 2019
10.2.5.3. Market
Forecast, 2020 – 2028
10.2.5.4. Compound
Annual Growth Rate (CAGR)
10.2.5.5. Regional
Bifurcation
10.2.5.5.1. North
America
10.2.5.5.1.1. Market
Estimation, 2015 – 2019
10.2.5.5.1.2. Market
Forecast, 2020 – 2028
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 – 2019
10.2.5.5.2.2. Market
Forecast, 2020 – 2028
10.2.5.5.3. Asia
Pacific
10.2.5.5.3.1. Market
Estimation, 2015 – 2019
10.2.5.5.3.2. Market
Forecast, 2020 – 2028
10.2.5.5.4. Middle
East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 – 2019
10.2.5.5.4.2. Market
Forecast, 2020 – 2028
10.2.5.5.5. Latin
America
10.2.5.5.5.1. Market
Estimation, 2015 – 2019
10.2.5.5.5.2. Market
Forecast, 2020 – 2028
10.3. Key
Segment for Channeling Investments
10.3.1. By
Product Form
11. Global
Probiotic Strains Market Analysis and Forecasts, 2020 – 2028
11.1. Overview
11.2. Global
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
11.2.1. Digestive
Health
11.2.1.1. Definition
11.2.1.2. Market
Estimation and Penetration, 2015 – 2019
11.2.1.3. Market
Forecast, 2020 – 2028
11.2.1.4. Compound
Annual Growth Rate (CAGR)
11.2.1.5. Regional
Bifurcation
11.2.1.5.1. North
America
11.2.1.5.1.1. Market
Estimation, 2015 – 2019
11.2.1.5.1.2. Market
Forecast, 2020 – 2028
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 – 2019
11.2.1.5.2.2. Market
Forecast, 2020 – 2028
11.2.1.5.3. Asia
Pacific
11.2.1.5.3.1. Market
Estimation, 2015 – 2019
11.2.1.5.3.2. Market
Forecast, 2020 – 2028
11.2.1.5.4. Middle
East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 – 2019
11.2.1.5.4.2. Market
Forecast, 2020 – 2028
11.2.1.5.5. Latin
America
11.2.1.5.5.1. Market
Estimation, 2015 – 2019
11.2.1.5.5.2. Market
Forecast, 2020 – 2028
11.2.2. Weight
Management
11.2.2.1. Definition
11.2.2.2. Market
Estimation and Penetration, 2015 – 2019
11.2.2.3. Market
Forecast, 2020 – 2028
11.2.2.4. Compound
Annual Growth Rate (CAGR)
11.2.2.5. Regional
Bifurcation
11.2.2.5.1. North
America
11.2.2.5.1.1. Market
Estimation, 2015 – 2019
11.2.2.5.1.2. Market
Forecast, 2020 – 2028
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 – 2019
11.2.2.5.2.2. Market
Forecast, 2020 – 2028
11.2.2.5.3. Asia
Pacific
11.2.2.5.3.1. Market
Estimation, 2015 – 2019
11.2.2.5.3.2. Market
Forecast, 2020 – 2028
11.2.2.5.4. Middle
East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 – 2019
11.2.2.5.4.2. Market
Forecast, 2020 – 2028
11.2.2.5.5. Latin
America
11.2.2.5.5.1. Market
Estimation, 2015 – 2019
11.2.2.5.5.2. Market
Forecast, 2020 – 2028
11.2.3. Immune
Health
11.2.3.1. Definition
11.2.3.2. Market
Estimation and Penetration, 2015 – 2019
11.2.3.3. Market
Forecast, 2020 – 2028
11.2.3.4. Compound
Annual Growth Rate (CAGR)
11.2.3.5. Regional
Bifurcation
11.2.3.5.1. North
America
11.2.3.5.1.1. Market
Estimation, 2015 – 2019
11.2.3.5.1.2. Market
Forecast, 2020 – 2028
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 – 2019
11.2.3.5.2.2. Market
Forecast, 2020 – 2028
11.2.3.5.3. Asia
Pacific
11.2.3.5.3.1. Market
Estimation, 2015 – 2019
11.2.3.5.3.2. Market
Forecast, 2020 – 2028
11.2.3.5.4. Middle
East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 – 2019
11.2.3.5.4.2. Market
Forecast, 2020 – 2028
11.2.3.5.5. Latin
America
11.2.3.5.5.1. Market
Estimation, 2015 – 2019
11.2.3.5.5.2. Market
Forecast, 2020 – 2028
11.2.4. Women’s
Health
11.2.4.1. Definition
11.2.4.2. Market
Estimation and Penetration, 2015 – 2019
11.2.4.3. Market
Forecast, 2020 – 2028
11.2.4.4. Compound
Annual Growth Rate (CAGR)
11.2.4.5. Regional
Bifurcation
11.2.4.5.1. North
America
11.2.4.5.1.1. Market
Estimation, 2015 – 2019
11.2.4.5.1.2. Market
Forecast, 2020 – 2028
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 – 2019
11.2.4.5.2.2. Market
Forecast, 2020 – 2028
11.2.4.5.3. Asia
Pacific
11.2.4.5.3.1. Market
Estimation, 2015 – 2019
11.2.4.5.3.2. Market
Forecast, 2020 – 2028
11.2.4.5.4. Middle
East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 – 2019
11.2.4.5.4.2. Market
Forecast, 2020 – 2028
11.2.4.5.5. Latin
America
11.2.4.5.5.1. Market
Estimation, 2015 – 2019
11.2.4.5.5.2. Market
Forecast, 2020 – 2028
11.2.5. Heart
Health
11.2.5.1. Definition
11.2.5.2. Market
Estimation and Penetration, 2015 – 2019
11.2.5.3. Market
Forecast, 2020 – 2028
11.2.5.4. Compound
Annual Growth Rate (CAGR)
11.2.5.5. Regional
Bifurcation
11.2.5.5.1. North
America
11.2.5.5.1.1. Market
Estimation, 2015 – 2019
11.2.5.5.1.2. Market
Forecast, 2020 – 2028
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 – 2019
11.2.5.5.2.2. Market
Forecast, 2020 – 2028
11.2.5.5.3. Asia
Pacific
11.2.5.5.3.1. Market
Estimation, 2015 – 2019
11.2.5.5.3.2. Market
Forecast, 2020 – 2028
11.2.5.5.4. Middle
East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 – 2019
11.2.5.5.4.2. Market
Forecast, 2020 – 2028
11.2.5.5.5. Latin
America
11.2.5.5.5.1. Market
Estimation, 2015 – 2019
11.2.5.5.5.2. Market
Forecast, 2020 – 2028
11.2.6. Oral
Health
11.2.6.1. Definition
11.2.6.2. Market
Estimation and Penetration, 2015 – 2019
11.2.6.3. Market
Forecast, 2020 – 2028
11.2.6.4. Compound
Annual Growth Rate (CAGR)
11.2.6.5. Regional
Bifurcation
11.2.6.5.1. North
America
11.2.6.5.1.1. Market
Estimation, 2015 – 2019
11.2.6.5.1.2. Market
Forecast, 2020 – 2028
11.2.6.5.2. Europe
11.2.6.5.2.1. Market
Estimation, 2015 – 2019
11.2.6.5.2.2. Market
Forecast, 2020 – 2028
11.2.6.5.3. Asia
Pacific
11.2.6.5.3.1. Market
Estimation, 2015 – 2019
11.2.6.5.3.2. Market
Forecast, 2020 – 2028
11.2.6.5.4. Middle
East and Africa
11.2.6.5.4.1. Market
Estimation, 2015 – 2019
11.2.6.5.4.2. Market
Forecast, 2020 – 2028
11.2.6.5.5. Latin
America
11.2.6.5.5.1. Market
Estimation, 2015 – 2019
11.2.6.5.5.2. Market
Forecast, 2020 – 2028
11.2.7. Colon
Health
11.2.7.1. Definition
11.2.7.2. Market
Estimation and Penetration, 2015 – 2019
11.2.7.3. Market
Forecast, 2020 – 2028
11.2.7.4. Compound
Annual Growth Rate (CAGR)
11.2.7.5. Regional
Bifurcation
11.2.7.5.1. North
America
11.2.7.5.1.1. Market
Estimation, 2015 – 2019
11.2.7.5.1.2. Market
Forecast, 2020 – 2028
11.2.7.5.2. Europe
11.2.7.5.2.1. Market
Estimation, 2015 – 2019
11.2.7.5.2.2. Market
Forecast, 2020 – 2028
11.2.7.5.3. Asia
Pacific
11.2.7.5.3.1. Market
Estimation, 2015 – 2019
11.2.7.5.3.2. Market
Forecast, 2020 – 2028
11.2.7.5.4. Middle
East and Africa
11.2.7.5.4.1. Market
Estimation, 2015 – 2019
11.2.7.5.4.2. Market
Forecast, 2020 – 2028
11.2.7.5.5. Latin
America
11.2.7.5.5.1. Market
Estimation, 2015 – 2019
11.2.7.5.5.2. Market
Forecast, 2020 – 2028
11.2.8. Bone
Health
11.2.8.1. Definition
11.2.8.2. Market
Estimation and Penetration, 2015 – 2019
11.2.8.3. Market
Forecast, 2020 – 2028
11.2.8.4. Compound
Annual Growth Rate (CAGR)
11.2.8.5. Regional
Bifurcation
11.2.8.5.1. North
America
11.2.8.5.1.1. Market
Estimation, 2015 – 2019
11.2.8.5.1.2. Market
Forecast, 2020 – 2028
11.2.8.5.2. Europe
11.2.8.5.2.1. Market
Estimation, 2015 – 2019
11.2.8.5.2.2. Market
Forecast, 2020 – 2028
11.2.8.5.3. Asia
Pacific
11.2.8.5.3.1. Market
Estimation, 2015 – 2019
11.2.8.5.3.2. Market
Forecast, 2020 – 2028
11.2.8.5.4. Middle
East and Africa
11.2.8.5.4.1. Market
Estimation, 2015 – 2019
11.2.8.5.4.2. Market
Forecast, 2020 – 2028
11.2.8.5.5. Latin
America
11.2.8.5.5.1. Market
Estimation, 2015 – 2019
11.2.8.5.5.2. Market
Forecast, 2020 – 2028
11.2.9. GI
Tract Health
11.2.9.1. Definition
11.2.9.2. Market
Estimation and Penetration, 2015 – 2019
11.2.9.3. Market
Forecast, 2020 – 2028
11.2.9.4. Compound
Annual Growth Rate (CAGR)
11.2.9.5. Regional
Bifurcation
11.2.9.5.1. North
America
11.2.9.5.1.1. Market
Estimation, 2015 – 2019
11.2.9.5.1.2. Market
Forecast, 2020 – 2028
11.2.9.5.2. Europe
11.2.9.5.2.1. Market
Estimation, 2015 – 2019
11.2.9.5.2.2. Market
Forecast, 2020 – 2028
11.2.9.5.3. Asia
Pacific
11.2.9.5.3.1. Market
Estimation, 2015 – 2019
11.2.9.5.3.2. Market
Forecast, 2020 – 2028
11.2.9.5.4. Middle
East and Africa
11.2.9.5.4.1. Market
Estimation, 2015 – 2019
11.2.9.5.4.2. Market
Forecast, 2020 – 2028
11.2.9.5.5. Latin
America
11.2.9.5.5.1. Market
Estimation, 2015 – 2019
11.2.9.5.5.2. Market
Forecast, 2020 – 2028
11.2.10. Others
11.2.10.1. Definition
11.2.10.2. Market
Estimation and Penetration, 2015 – 2019
11.2.10.3. Market
Forecast, 2020 – 2028
11.2.10.4. Compound
Annual Growth Rate (CAGR)
11.2.10.5. Regional
Bifurcation
11.2.10.5.1. North
America
11.2.10.5.1.1. Market
Estimation, 2015 – 2019
11.2.10.5.1.2. Market
Forecast, 2020 – 2028
11.2.10.5.2. Europe
11.2.10.5.2.1. Market
Estimation, 2015 – 2019
11.2.10.5.2.2. Market
Forecast, 2020 – 2028
11.2.10.5.3. Asia
Pacific
11.2.10.5.3.1. Market
Estimation, 2015 – 2019
11.2.10.5.3.2. Market
Forecast, 2020 – 2028
11.2.10.5.4. Middle
East and Africa
11.2.10.5.4.1. Market
Estimation, 2015 – 2019
11.2.10.5.4.2. Market
Forecast, 2020 – 2028
11.2.10.5.5. Latin
America
11.2.10.5.5.1. Market
Estimation, 2015 – 2019
11.2.10.5.5.2. Market
Forecast, 2020 – 2028
11.3. Key
Segment for Channeling Investments
11.3.1. By
Health Indication
12. Global
Probiotic Strains Market Analysis and Forecasts, 2020 – 2028
12.1. Overview
12.2. Global
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
12.2.1. Food
and Beverage (Definition, Market Estimation and Penetration, 2015 – 2019,
Market Estimation (2015 – 2019), Market Forecast (2020 – 2028), Compound Annual
Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific,
Middle East and Africa, Latin America) and Information on Bakery, Dairy,
Beverages, Others)
12.2.1.1. Bakery
12.2.1.2. Dairy
12.2.1.3. Beverages
12.2.1.4. Others
12.2.2. Nutritional
and Dietary Supplements
12.2.2.1. Definition
12.2.2.2. Market
Estimation and Penetration, 2015 – 2019
12.2.2.3. Market
Forecast, 2020 – 2028
12.2.2.4. Compound
Annual Growth Rate (CAGR)
12.2.2.5. Regional
Bifurcation
12.2.2.5.1. North
America
12.2.2.5.1.1. Market
Estimation, 2015 – 2019
12.2.2.5.1.2. Market
Forecast, 2020 – 2028
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 – 2019
12.2.2.5.2.2. Market
Forecast, 2020 – 2028
12.2.2.5.3. Asia
Pacific
12.2.2.5.3.1. Market
Estimation, 2015 – 2019
12.2.2.5.3.2. Market
Forecast, 2020 – 2028
12.2.2.5.4. Middle
East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 – 2019
12.2.2.5.4.2. Market
Forecast, 2020 – 2028
12.2.2.5.5. Latin
America
12.2.2.5.5.1. Market
Estimation, 2015 – 2019
12.2.2.5.5.2. Market
Forecast, 2020 – 2028
12.2.3. Animal
Feed
12.2.3.1. Definition
12.2.3.2. Market
Estimation and Penetration, 2015 – 2019
12.2.3.3. Market
Forecast, 2020 – 2028
12.2.3.4. Compound
Annual Growth Rate (CAGR)
12.2.3.5. Regional
Bifurcation
12.2.3.5.1. North
America
12.2.3.5.1.1. Market
Estimation, 2015 – 2019
12.2.3.5.1.2. Market
Forecast, 2020 – 2028
12.2.3.5.2. Europe
12.2.3.5.2.1. Market
Estimation, 2015 – 2019
12.2.3.5.2.2. Market
Forecast, 2020 – 2028
12.2.3.5.3. Asia
Pacific
12.2.3.5.3.1. Market
Estimation, 2015 – 2019
12.2.3.5.3.2. Market
Forecast, 2020 – 2028
12.2.3.5.4. Middle
East and Africa
12.2.3.5.4.1. Market
Estimation, 2015 – 2019
12.2.3.5.4.2. Market
Forecast, 2020 – 2028
12.2.3.5.5. Latin
America
12.2.3.5.5.1. Market
Estimation, 2015 – 2019
12.2.3.5.5.2. Market
Forecast, 2020 – 2028
12.2.4. Others
12.2.4.1. Definition
12.2.4.2. Market
Estimation and Penetration, 2015 – 2019
12.2.4.3. Market
Forecast, 2020 – 2028
12.2.4.4. Compound
Annual Growth Rate (CAGR)
12.2.4.5. Regional
Bifurcation
12.2.4.5.1. North
America
12.2.4.5.1.1. Market
Estimation, 2015 – 2019
12.2.4.5.1.2. Market
Forecast, 2020 – 2028
12.2.4.5.2. Europe
12.2.4.5.2.1. Market
Estimation, 2015 – 2019
12.2.4.5.2.2. Market
Forecast, 2020 – 2028
12.2.4.5.3. Asia
Pacific
12.2.4.5.3.1. Market
Estimation, 2015 – 2019
12.2.4.5.3.2. Market
Forecast, 2020 – 2028
12.2.4.5.4. Middle
East and Africa
12.2.4.5.4.1. Market
Estimation, 2015 – 2019
12.2.4.5.4.2. Market
Forecast, 2020 – 2028
12.2.4.5.5. Latin
America
12.2.4.5.5.1. Market
Estimation, 2015 – 2019
12.2.4.5.5.2. Market
Forecast, 2020 – 2028
12.3. Key
Segment for Channeling Investments
12.3.1. By
Application
13. North
America Probiotic Strains Market Analysis and Forecasts, 2020 - 2028
13.1. Overview
13.1.1. North
America Probiotic Strains Market Revenue (US$ Mn)
13.2. North
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1. Lactobacillus
13.2.1.1. Lactobacillus
Acidophilus
13.2.1.2. Lactobacillus
Rhamnosus GG (LGG)
13.2.1.3. Others
13.2.2. Bifidobacterium
13.2.2.1. Bifidobacterium
Bifidum
13.2.2.2. Bifidobacterium
Breve
13.2.2.3. Bifidobacterium
Animalis
13.2.2.4. Others
13.2.3. Saccharomyces
13.2.4. Streptococcus
13.2.5. Enterococcus
13.2.6. Escherichia
13.2.7. Bacillus
13.2.8. Others
13.3. North
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
13.3.1. Single
Stains
13.3.2. Multi
Strains
13.4. North
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product
Form
13.4.1. Powder
13.4.2. Capsules
13.4.3. Liquids
13.4.4. Lozenges
13.4.5. Others
13.5. North
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
13.5.1. Digestive
Health
13.5.2. Weight
Management
13.5.3. Immune
Health
13.5.4. Women’s
Health
13.5.5. Heart
Health
13.5.6. Oral
Health
13.5.7. Colon
Health
13.5.8. Bone
Health
13.5.9. GI
Tract Health
13.5.10. Others
13.6. North
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1. Food
and Beverage
13.6.1.1. Bakery
13.6.1.2. Dairy
13.6.1.3. Beverages
13.6.1.4. Others
13.6.2. Nutritional
and Dietary Supplements
13.6.3. Animal
Feed
13.6.4. Others
13.7. North
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1. U.S
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
13.7.1.1.1. Lactobacillus
13.7.1.1.1.1. Lactobacillus
Acidophilus
13.7.1.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
13.7.1.1.1.3. Others
13.7.1.1.2. Bifidobacterium
13.7.1.1.2.1. Bifidobacterium
Bifidum
13.7.1.1.2.2. Bifidobacterium
Breve
13.7.1.1.2.3. Bifidobacterium
Animalis
13.7.1.1.2.4. Others
13.7.1.1.3. Saccharomyces
13.7.1.1.4. Streptococcus
13.7.1.1.5. Enterococcus
13.7.1.1.6. Escherichia
13.7.1.1.7. Bacillus
13.7.1.1.8. Others
13.7.1.2. U.S
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
13.7.1.2.1. Single
Stains
13.7.1.2.2. Multi
Strains
13.7.1.3. U.S
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
13.7.1.3.1. Powder
13.7.1.3.2. Capsules
13.7.1.3.3. Liquids
13.7.1.3.4. Lozenges
13.7.1.3.5. Others
13.7.1.4. U.S
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
13.7.1.4.1. Digestive
Health
13.7.1.4.2. Weight
Management
13.7.1.4.3. Immune
Health
13.7.1.4.4. Women’s
Health
13.7.1.4.5. Heart
Health
13.7.1.4.6. Oral
Health
13.7.1.4.7. Colon
Health
13.7.1.4.8. Bone
Health
13.7.1.4.9. GI
Tract Health
13.7.1.4.10. Others
13.7.1.5. U.S
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
13.7.1.5.1. Food
and Beverage
13.7.1.5.1.1. Bakery
13.7.1.5.1.2. Dairy
13.7.1.5.1.3. Beverages
13.7.1.5.1.4. Others
13.7.1.5.2. Nutritional
and Dietary Supplements
13.7.1.5.3. Animal
Feed
13.7.1.5.4. Others
13.7.2. Canada
13.7.2.1. Canada
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
13.7.2.1.1. Lactobacillus
13.7.2.1.1.1. Lactobacillus
Acidophilus
13.7.2.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
13.7.2.1.1.3. Others
13.7.2.1.2. Bifidobacterium
13.7.2.1.2.1. Bifidobacterium
Bifidum
13.7.2.1.2.2. Bifidobacterium
Breve
13.7.2.1.2.3. Bifidobacterium
Animalis
13.7.2.1.2.4. Others
13.7.2.1.3. Saccharomyces
13.7.2.1.4. Streptococcus
13.7.2.1.5. Enterococcus
13.7.2.1.6. Escherichia
13.7.2.1.7. Bacillus
13.7.2.1.8. Others
13.7.2.2. Canada
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
13.7.2.2.1. Single
Stains
13.7.2.2.2. Multi
Strains
13.7.2.3. Canada
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
13.7.2.3.1. Powder
13.7.2.3.2. Capsules
13.7.2.3.3. Liquids
13.7.2.3.4. Lozenges
13.7.2.3.5. Others
13.7.2.4. Canada
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
13.7.2.4.1. Digestive
Health
13.7.2.4.2. Weight
Management
13.7.2.4.3. Immune
Health
13.7.2.4.4. Women’s
Health
13.7.2.4.5. Heart
Health
13.7.2.4.6. Oral
Health
13.7.2.4.7. Colon
Health
13.7.2.4.8. Bone
Health
13.7.2.4.9. GI
Tract Health
13.7.2.4.10. Others
13.7.2.5. Canada
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
13.7.2.5.1. Food
and Beverage
13.7.2.5.1.1. Bakery
13.7.2.5.1.2. Dairy
13.7.2.5.1.3. Beverages
13.7.2.5.1.4. Others
13.7.2.5.2. Nutritional
and Dietary Supplements
13.7.2.5.3. Animal
Feed
13.7.2.5.4. Others
13.7.3. Mexico
13.7.3.1. Mexico
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
13.7.3.1.1. Lactobacillus
13.7.3.1.1.1. Lactobacillus
Acidophilus
13.7.3.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
13.7.3.1.1.3. Others
13.7.3.1.2. Bifidobacterium
13.7.3.1.2.1. Bifidobacterium
Bifidum
13.7.3.1.2.2. Bifidobacterium
Breve
13.7.3.1.2.3. Bifidobacterium
Animalis
13.7.3.1.2.4. Others
13.7.3.1.3. Saccharomyces
13.7.3.1.4. Streptococcus
13.7.3.1.5. Enterococcus
13.7.3.1.6. Escherichia
13.7.3.1.7. Bacillus
13.7.3.1.8. Others
13.7.3.2. Mexico
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
13.7.3.2.1. Single
Stains
13.7.3.2.2. Multi
Strains
13.7.3.3. Mexico
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
13.7.3.3.1. Powder
13.7.3.3.2. Capsules
13.7.3.3.3. Liquids
13.7.3.3.4. Lozenges
13.7.3.3.5. Others
13.7.3.4. Mexico
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
13.7.3.4.1. Digestive
Health
13.7.3.4.2. Weight
Management
13.7.3.4.3. Immune
Health
13.7.3.4.4. Women’s
Health
13.7.3.4.5. Heart
Health
13.7.3.4.6. Oral
Health
13.7.3.4.7. Colon
Health
13.7.3.4.8. Bone
Health
13.7.3.4.9. GI
Tract Health
13.7.3.4.10. Others
13.7.3.5. Mexico
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
13.7.3.5.1. Food
and Beverage
13.7.3.5.1.1. Bakery
13.7.3.5.1.2. Dairy
13.7.3.5.1.3. Beverages
13.7.3.5.1.4. Others
13.7.3.5.2. Nutritional
and Dietary Supplements
13.7.3.5.3. Animal
Feed
13.7.3.5.4. Others
13.7.4. Rest of
North America
13.7.4.1. Rest
of North America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Type
13.7.4.1.1. Lactobacillus
13.7.4.1.1.1. Lactobacillus
Acidophilus
13.7.4.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
13.7.4.1.1.3. Others
13.7.4.1.2. Bifidobacterium
13.7.4.1.2.1. Bifidobacterium
Bifidum
13.7.4.1.2.2. Bifidobacterium
Breve
13.7.4.1.2.3. Bifidobacterium
Animalis
13.7.4.1.2.4. Others
13.7.4.1.3. Saccharomyces
13.7.4.1.4. Streptococcus
13.7.4.1.5. Enterococcus
13.7.4.1.6. Escherichia
13.7.4.1.7. Bacillus
13.7.4.1.8. Others
13.7.4.2. Rest
of North America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Formulation
13.7.4.2.1. Single
Stains
13.7.4.2.2. Multi
Strains
13.7.4.3. Rest
of North America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Product Form
13.7.4.3.1. Powder
13.7.4.3.2. Capsules
13.7.4.3.3. Liquids
13.7.4.3.4. Lozenges
13.7.4.3.5. Others
13.7.4.4. Rest
of North America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Health Indication
13.7.4.4.1. Digestive
Health
13.7.4.4.2. Weight
Management
13.7.4.4.3. Immune
Health
13.7.4.4.4. Women’s
Health
13.7.4.4.5. Heart
Health
13.7.4.4.6. Oral
Health
13.7.4.4.7. Colon
Health
13.7.4.4.8. Bone
Health
13.7.4.4.9. GI
Tract Health
13.7.4.4.10. Others
13.7.4.5. Rest
of North America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.4.5.1. Food
and Beverage
13.7.4.5.1.1. Bakery
13.7.4.5.1.2. Dairy
13.7.4.5.1.3. Beverages
13.7.4.5.1.4. Others
13.7.4.5.2. Nutritional
and Dietary Supplements
13.7.4.5.3. Animal
Feed
13.7.4.5.4. Others
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By Type
13.8.3. By
Formulation
13.8.4. By
Product Form
13.8.5. By
Health Indication
13.8.6. By
Application
14. Europe
Probiotic Strains Market Analysis and Forecasts, 2020 - 2028
14.1. Overview
14.1.1. Europe
Probiotic Strains Market Revenue (US$ Mn)
14.2. Europe
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Lactobacillus
14.2.1.1. Lactobacillus
Acidophilus
14.2.1.2. Lactobacillus
Rhamnosus GG (LGG)
14.2.1.3. Others
14.2.2. Bifidobacterium
14.2.2.1. Bifidobacterium
Bifidum
14.2.2.2. Bifidobacterium
Breve
14.2.2.3. Bifidobacterium
Animalis
14.2.2.4. Others
14.2.3. Saccharomyces
14.2.4. Streptococcus
14.2.5. Enterococcus
14.2.6. Escherichia
14.2.7. Bacillus
14.2.8. Others
14.3. Europe
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
14.3.1. Single
Stains
14.3.2. Multi
Strains
14.4. Europe
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
14.4.1. Powder
14.4.2. Capsules
14.4.3. Liquids
14.4.4. Lozenges
14.4.5. Others
14.5. Europe
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
14.5.1. Digestive
Health
14.5.2. Weight
Management
14.5.3. Immune
Health
14.5.4. Women’s
Health
14.5.5. Heart
Health
14.5.6. Oral
Health
14.5.7. Colon
Health
14.5.8. Bone
Health
14.5.9. GI
Tract Health
14.5.10. Others
14.6. Europe
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1. Food
and Beverage
14.6.1.1. Bakery
14.6.1.2. Dairy
14.6.1.3. Beverages
14.6.1.4. Others
14.6.2. Nutritional
and Dietary Supplements
14.6.3. Animal
Feed
14.6.4. Others
14.7. Europe
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
14.7.1.1.1. Lactobacillus
14.7.1.1.1.1. Lactobacillus
Acidophilus
14.7.1.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
14.7.1.1.1.3. Others
14.7.1.1.2. Bifidobacterium
14.7.1.1.2.1. Bifidobacterium
Bifidum
14.7.1.1.2.2. Bifidobacterium
Breve
14.7.1.1.2.3. Bifidobacterium
Animalis
14.7.1.1.2.4. Others
14.7.1.1.3. Saccharomyces
14.7.1.1.4. Streptococcus
14.7.1.1.5. Enterococcus
14.7.1.1.6. Escherichia
14.7.1.1.7. Bacillus
14.7.1.1.8. Others
14.7.1.2. France
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
14.7.1.2.1. Single
Stains
14.7.1.2.2. Multi
Strains
14.7.1.3. France
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
14.7.1.3.1. Powder
14.7.1.3.2. Capsules
14.7.1.3.3. Liquids
14.7.1.3.4. Lozenges
14.7.1.3.5. Others
14.7.1.4. France
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
14.7.1.4.1. Digestive
Health
14.7.1.4.2. Weight
Management
14.7.1.4.3. Immune
Health
14.7.1.4.4. Women’s
Health
14.7.1.4.5. Heart
Health
14.7.1.4.6. Oral
Health
14.7.1.4.7. Colon
Health
14.7.1.4.8. Bone
Health
14.7.1.4.9. GI
Tract Health
14.7.1.4.10. Others
14.7.1.5. France
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
14.7.1.5.1. Food
and Beverage
14.7.1.5.1.1. Bakery
14.7.1.5.1.2. Dairy
14.7.1.5.1.3. Beverages
14.7.1.5.1.4. Others
14.7.1.5.2. Nutritional
and Dietary Supplements
14.7.1.5.3. Animal
Feed
14.7.1.5.4. Others
14.7.2. The UK
14.7.2.1. The
UK Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
14.7.2.1.1. Lactobacillus
14.7.2.1.1.1. Lactobacillus
Acidophilus
14.7.2.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
14.7.2.1.1.3. Others
14.7.2.1.2. Bifidobacterium
14.7.2.1.2.1. Bifidobacterium
Bifidum
14.7.2.1.2.2. Bifidobacterium
Breve
14.7.2.1.2.3. Bifidobacterium
Animalis
14.7.2.1.2.4. Others
14.7.2.1.3. Saccharomyces
14.7.2.1.4. Streptococcus
14.7.2.1.5. Enterococcus
14.7.2.1.6. Escherichia
14.7.2.1.7. Bacillus
14.7.2.1.8. Others
14.7.2.2. The
UK Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
14.7.2.2.1. Single
Stains
14.7.2.2.2. Multi
Strains
14.7.2.3. The
UK Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
14.7.2.3.1. Powder
14.7.2.3.2. Capsules
14.7.2.3.3. Liquids
14.7.2.3.4. Lozenges
14.7.2.3.5. Others
14.7.2.4. The
UK Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
14.7.2.4.1. Digestive
Health
14.7.2.4.2. Weight
Management
14.7.2.4.3. Immune
Health
14.7.2.4.4. Women’s
Health
14.7.2.4.5. Heart
Health
14.7.2.4.6. Oral
Health
14.7.2.4.7. Colon
Health
14.7.2.4.8. Bone
Health
14.7.2.4.9. GI
Tract Health
14.7.2.4.10. Others
14.7.2.5. The
UK Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
14.7.2.5.1. Food
and Beverage
14.7.2.5.1.1. Bakery
14.7.2.5.1.2. Dairy
14.7.2.5.1.3. Beverages
14.7.2.5.1.4. Others
14.7.2.5.2. Nutritional
and Dietary Supplements
14.7.2.5.3. Animal
Feed
14.7.2.5.4. Others
14.7.3. Spain
14.7.3.1. Spain
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
14.7.3.1.1. Lactobacillus
14.7.3.1.1.1. Lactobacillus
Acidophilus
14.7.3.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
14.7.3.1.1.3. Others
14.7.3.1.2. Bifidobacterium
14.7.3.1.2.1. Bifidobacterium
Bifidum
14.7.3.1.2.2. Bifidobacterium
Breve
14.7.3.1.2.3. Bifidobacterium
Animalis
14.7.3.1.2.4. Others
14.7.3.1.3. Saccharomyces
14.7.3.1.4. Streptococcus
14.7.3.1.5. Enterococcus
14.7.3.1.6. Escherichia
14.7.3.1.7. Bacillus
14.7.3.1.8. Others
14.7.3.2. Spain
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
14.7.3.2.1. Single
Stains
14.7.3.2.2. Multi
Strains
14.7.3.3. Spain
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
14.7.3.3.1. Powder
14.7.3.3.2. Capsules
14.7.3.3.3. Liquids
14.7.3.3.4. Lozenges
14.7.3.3.5. Others
14.7.3.4. Spain
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
14.7.3.4.1. Digestive
Health
14.7.3.4.2. Weight
Management
14.7.3.4.3. Immune
Health
14.7.3.4.4. Women’s
Health
14.7.3.4.5. Heart
Health
14.7.3.4.6. Oral
Health
14.7.3.4.7. Colon
Health
14.7.3.4.8. Bone
Health
14.7.3.4.9. GI
Tract Health
14.7.3.4.10. Others
14.7.3.5. Spain
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
14.7.3.5.1. Food
and Beverage
14.7.3.5.1.1. Bakery
14.7.3.5.1.2. Dairy
14.7.3.5.1.3. Beverages
14.7.3.5.1.4. Others
14.7.3.5.2. Nutritional
and Dietary Supplements
14.7.3.5.3. Animal
Feed
14.7.3.5.4. Others
14.7.4. Germany
14.7.4.1. Germany
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
14.7.4.1.1. Lactobacillus
14.7.4.1.1.1. Lactobacillus
Acidophilus
14.7.4.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
14.7.4.1.1.3. Others
14.7.4.1.2. Bifidobacterium
14.7.4.1.2.1. Bifidobacterium
Bifidum
14.7.4.1.2.2. Bifidobacterium
Breve
14.7.4.1.2.3. Bifidobacterium
Animalis
14.7.4.1.2.4. Others
14.7.4.1.3. Saccharomyces
14.7.4.1.4. Streptococcus
14.7.4.1.5. Enterococcus
14.7.4.1.6. Escherichia
14.7.4.1.7. Bacillus
14.7.4.1.8. Others
14.7.4.2. Germany
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
14.7.4.2.1. Single
Stains
14.7.4.2.2. Multi
Strains
14.7.4.3. Germany
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
14.7.4.3.1. Powder
14.7.4.3.2. Capsules
14.7.4.3.3. Liquids
14.7.4.3.4. Lozenges
14.7.4.3.5. Others
14.7.4.4. Germany
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
14.7.4.4.1. Digestive
Health
14.7.4.4.2. Weight
Management
14.7.4.4.3. Immune
Health
14.7.4.4.4. Women’s
Health
14.7.4.4.5. Heart
Health
14.7.4.4.6. Oral
Health
14.7.4.4.7. Colon
Health
14.7.4.4.8. Bone
Health
14.7.4.4.9. GI Tract
Health
14.7.4.4.10. Others
14.7.4.5. Germany
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
14.7.4.5.1. Food
and Beverage
14.7.4.5.1.1. Bakery
14.7.4.5.1.2. Dairy
14.7.4.5.1.3. Beverages
14.7.4.5.1.4. Others
14.7.4.5.2. Nutritional
and Dietary Supplements
14.7.4.5.3. Animal
Feed
14.7.4.5.4. Others
14.7.5. Italy
14.7.5.1. Italy
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
14.7.5.1.1. Lactobacillus
14.7.5.1.1.1. Lactobacillus
Acidophilus
14.7.5.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
14.7.5.1.1.3. Others
14.7.5.1.2. Bifidobacterium
14.7.5.1.2.1. Bifidobacterium
Bifidum
14.7.5.1.2.2. Bifidobacterium
Breve
14.7.5.1.2.3. Bifidobacterium
Animalis
14.7.5.1.2.4. Others
14.7.5.1.3. Saccharomyces
14.7.5.1.4. Streptococcus
14.7.5.1.5. Enterococcus
14.7.5.1.6. Escherichia
14.7.5.1.7. Bacillus
14.7.5.1.8. Others
14.7.5.2. Italy
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
14.7.5.2.1. Single
Stains
14.7.5.2.2. Multi
Strains
14.7.5.3. Italy
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
14.7.5.3.1. Powder
14.7.5.3.2. Capsules
14.7.5.3.3. Liquids
14.7.5.3.4. Lozenges
14.7.5.3.5. Others
14.7.5.4. Italy
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
14.7.5.4.1. Digestive
Health
14.7.5.4.2. Weight
Management
14.7.5.4.3. Immune
Health
14.7.5.4.4. Women’s
Health
14.7.5.4.5. Heart
Health
14.7.5.4.6. Oral
Health
14.7.5.4.7. Colon
Health
14.7.5.4.8. Bone
Health
14.7.5.4.9. GI
Tract Health
14.7.5.4.10. Others
14.7.5.5. Italy
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
14.7.5.5.1. Food
and Beverage
14.7.5.5.1.1. Bakery
14.7.5.5.1.2. Dairy
14.7.5.5.1.3. Beverages
14.7.5.5.1.4. Others
14.7.5.5.2. Nutritional
and Dietary Supplements
14.7.5.5.3. Animal
Feed
14.7.5.5.4. Others
14.7.6. Nordic
Countries
14.7.6.1. Nordic
Countries Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
14.7.6.1.1. Lactobacillus
14.7.6.1.1.1. Lactobacillus
Acidophilus
14.7.6.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
14.7.6.1.1.3. Others
14.7.6.1.2. Bifidobacterium
14.7.6.1.2.1. Bifidobacterium
Bifidum
14.7.6.1.2.2. Bifidobacterium
Breve
14.7.6.1.2.3. Bifidobacterium
Animalis
14.7.6.1.2.4. Others
14.7.6.1.3. Saccharomyces
14.7.6.1.4. Streptococcus
14.7.6.1.5. Enterococcus
14.7.6.1.6. Escherichia
14.7.6.1.7. Bacillus
14.7.6.1.8. Others
14.7.6.2. Nordic
Countries Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Formulation
14.7.6.2.1. Single
Stains
14.7.6.2.2. Multi
Strains
14.7.6.3. Nordic
Countries Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product
Form
14.7.6.3.1. Powder
14.7.6.3.2. Capsules
14.7.6.3.3. Liquids
14.7.6.3.4. Lozenges
14.7.6.3.5. Others
14.7.6.4. Nordic
Countries Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
14.7.6.4.1. Digestive
Health
14.7.6.4.2. Weight
Management
14.7.6.4.3. Immune
Health
14.7.6.4.4. Women’s
Health
14.7.6.4.5. Heart
Health
14.7.6.4.6. Oral
Health
14.7.6.4.7. Colon
Health
14.7.6.4.8. Bone
Health
14.7.6.4.9. GI
Tract Health
14.7.6.4.10. Others
14.7.6.5. Nordic
Countries Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.6.5.1. Food
and Beverage
14.7.6.5.1.1. Bakery
14.7.6.5.1.2. Dairy
14.7.6.5.1.3. Beverages
14.7.6.5.1.4. Others
14.7.6.5.2. Nutritional
and Dietary Supplements
14.7.6.5.3. Animal
Feed
14.7.6.5.4. Others
14.7.6.6. Nordic
Countries Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux
Union Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
14.7.7.1.1. Lactobacillus
14.7.7.1.1.1. Lactobacillus
Acidophilus
14.7.7.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
14.7.7.1.1.3. Others
14.7.7.1.2. Bifidobacterium
14.7.7.1.2.1. Bifidobacterium
Bifidum
14.7.7.1.2.2. Bifidobacterium
Breve
14.7.7.1.2.3. Bifidobacterium
Animalis
14.7.7.1.2.4. Others
14.7.7.1.3. Saccharomyces
14.7.7.1.4. Streptococcus
14.7.7.1.5. Enterococcus
14.7.7.1.6. Escherichia
14.7.7.1.7. Bacillus
14.7.7.1.8. Others
14.7.7.2. Benelux
Union Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
14.7.7.2.1. Single
Stains
14.7.7.2.2. Multi
Strains
14.7.7.3. Benelux
Union Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
14.7.7.3.1. Powder
14.7.7.3.2. Capsules
14.7.7.3.3. Liquids
14.7.7.3.4. Lozenges
14.7.7.3.5. Others
14.7.7.4. Benelux
Union Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
14.7.7.4.1. Digestive
Health
14.7.7.4.2. Weight
Management
14.7.7.4.3. Immune
Health
14.7.7.4.4. Women’s
Health
14.7.7.4.5. Heart
Health
14.7.7.4.6. Oral
Health
14.7.7.4.7. Colon
Health
14.7.7.4.8. Bone
Health
14.7.7.4.9. GI
Tract Health
14.7.7.4.10. Others
14.7.7.5. Benelux
Union Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
14.7.7.5.1. Food
and Beverage
14.7.7.5.1.1. Bakery
14.7.7.5.1.2. Dairy
14.7.7.5.1.3. Beverages
14.7.7.5.1.4. Others
14.7.7.5.2. Nutritional
and Dietary Supplements
14.7.7.5.3. Animal
Feed
14.7.7.5.4. Others
14.7.7.6. Benelux
Union Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The
Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest
of Europe Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
14.7.8.1.1. Lactobacillus
14.7.8.1.1.1. Lactobacillus
Acidophilus
14.7.8.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
14.7.8.1.1.3. Others
14.7.8.1.2. Bifidobacterium
14.7.8.1.2.1. Bifidobacterium
Bifidum
14.7.8.1.2.2. Bifidobacterium
Breve
14.7.8.1.2.3. Bifidobacterium
Animalis
14.7.8.1.2.4. Others
14.7.8.1.3. Saccharomyces
14.7.8.1.4. Streptococcus
14.7.8.1.5. Enterococcus
14.7.8.1.6. Escherichia
14.7.8.1.7. Bacillus
14.7.8.1.8. Others
14.7.8.2. Rest
of Europe Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
14.7.8.2.1. Single
Stains
14.7.8.2.2. Multi
Strains
14.7.8.3. Rest
of Europe Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product
Form
14.7.8.3.1. Powder
14.7.8.3.2. Capsules
14.7.8.3.3. Liquids
14.7.8.3.4. Lozenges
14.7.8.3.5. Others
14.7.8.4. Rest
of Europe Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
14.7.8.4.1. Digestive
Health
14.7.8.4.2. Weight
Management
14.7.8.4.3. Immune
Health
14.7.8.4.4. Women’s
Health
14.7.8.4.5. Heart
Health
14.7.8.4.6. Oral
Health
14.7.8.4.7. Colon
Health
14.7.8.4.8. Bone
Health
14.7.8.4.9. GI
Tract Health
14.7.8.4.10. Others
14.7.8.5. Rest
of Europe Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.8.5.1. Food
and Beverage
14.7.8.5.1.1. Bakery
14.7.8.5.1.2. Dairy
14.7.8.5.1.3. Beverages
14.7.8.5.1.4. Others
14.7.8.5.2. Nutritional
and Dietary Supplements
14.7.8.5.3. Animal
Feed
14.7.8.5.4. Others
14.8. Key
Segment for Channeling Investments
14.8.1. By
Country
14.8.2. By Type
14.8.3. By
Formulation
14.8.4. By
Product Form
14.8.5. By
Health Indication
14.8.6. By
Application
15. Asia
Pacific Probiotic Strains Market Analysis and Forecasts, 2020 - 2028
15.1. Overview
15.1.1. Asia
Pacific Probiotic Strains Market Revenue (US$ Mn)
15.2. Asia
Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
15.2.1. Lactobacillus
15.2.1.1. Lactobacillus
Acidophilus
15.2.1.2. Lactobacillus
Rhamnosus GG (LGG)
15.2.1.3. Others
15.2.2. Bifidobacterium
15.2.2.1. Bifidobacterium
Bifidum
15.2.2.2. Bifidobacterium
Breve
15.2.2.3. Bifidobacterium
Animalis
15.2.2.4. Others
15.2.3. Saccharomyces
15.2.4. Streptococcus
15.2.5. Enterococcus
15.2.6. Escherichia
15.2.7. Bacillus
15.2.8. Others
15.3. Asia
Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
15.3.1. Single Stains
15.3.2. Multi
Strains
15.4. Asia
Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product
Form
15.4.1. Powder
15.4.2. Capsules
15.4.3. Liquids
15.4.4. Lozenges
15.4.5. Others
15.5. Asia
Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
15.5.1. Digestive
Health
15.5.2. Weight
Management
15.5.3. Immune
Health
15.5.4. Women’s
Health
15.5.5. Heart
Health
15.5.6. Oral
Health
15.5.7. Colon
Health
15.5.8. Bone
Health
15.5.9. GI
Tract Health
15.5.10. Others
15.6. Asia
Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1. Food
and Beverage
15.6.1.1. Bakery
15.6.1.2. Dairy
15.6.1.3. Beverages
15.6.1.4. Others
15.6.2. Nutritional
and Dietary Supplements
15.6.3. Animal
Feed
15.6.4. Others
15.7. Asia
Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1. China
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
15.7.1.1.1. Lactobacillus
15.7.1.1.1.1. Lactobacillus
Acidophilus
15.7.1.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
15.7.1.1.1.3. Others
15.7.1.1.2. Bifidobacterium
15.7.1.1.2.1. Bifidobacterium
Bifidum
15.7.1.1.2.2. Bifidobacterium
Breve
15.7.1.1.2.3. Bifidobacterium
Animalis
15.7.1.1.2.4. Others
15.7.1.1.3. Saccharomyces
15.7.1.1.4. Streptococcus
15.7.1.1.5. Enterococcus
15.7.1.1.6. Escherichia
15.7.1.1.7. Bacillus
15.7.1.1.8. Others
15.7.1.2. China
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
15.7.1.2.1. Single
Stains
15.7.1.2.2. Multi
Strains
15.7.1.3. China
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
15.7.1.3.1. Powder
15.7.1.3.2. Capsules
15.7.1.3.3. Liquids
15.7.1.3.4. Lozenges
15.7.1.3.5. Others
15.7.1.4. China
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
15.7.1.4.1. Digestive
Health
15.7.1.4.2. Weight
Management
15.7.1.4.3. Immune
Health
15.7.1.4.4. Women’s
Health
15.7.1.4.5. Heart
Health
15.7.1.4.6. Oral
Health
15.7.1.4.7. Colon
Health
15.7.1.4.8. Bone
Health
15.7.1.4.9. GI
Tract Health
15.7.1.4.10. Others
15.7.1.5. China
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
15.7.1.5.1. Food
and Beverage
15.7.1.5.1.1. Bakery
15.7.1.5.1.2. Dairy
15.7.1.5.1.3. Beverages
15.7.1.5.1.4. Others
15.7.1.5.2. Nutritional
and Dietary Supplements
15.7.1.5.3. Animal
Feed
15.7.1.5.4. Others
15.7.2. Japan
15.7.2.1. Japan
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
15.7.2.1.1. Lactobacillus
15.7.2.1.1.1. Lactobacillus
Acidophilus
15.7.2.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
15.7.2.1.1.3. Others
15.7.2.1.2. Bifidobacterium
15.7.2.1.2.1. Bifidobacterium
Bifidum
15.7.2.1.2.2. Bifidobacterium
Breve
15.7.2.1.2.3. Bifidobacterium
Animalis
15.7.2.1.2.4. Others
15.7.2.1.3. Saccharomyces
15.7.2.1.4. Streptococcus
15.7.2.1.5. Enterococcus
15.7.2.1.6. Escherichia
15.7.2.1.7. Bacillus
15.7.2.1.8. Others
15.7.2.2. Japan
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
15.7.2.2.1. Single
Stains
15.7.2.2.2. Multi
Strains
15.7.2.3. Japan
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
15.7.2.3.1. Powder
15.7.2.3.2. Capsules
15.7.2.3.3. Liquids
15.7.2.3.4. Lozenges
15.7.2.3.5. Others
15.7.2.4. Japan
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
15.7.2.4.1. Digestive
Health
15.7.2.4.2. Weight
Management
15.7.2.4.3. Immune
Health
15.7.2.4.4. Women’s
Health
15.7.2.4.5. Heart
Health
15.7.2.4.6. Oral
Health
15.7.2.4.7. Colon
Health
15.7.2.4.8. Bone
Health
15.7.2.4.9. GI
Tract Health
15.7.2.4.10. Others
15.7.2.5. Japan
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
15.7.2.5.1. Food
and Beverage
15.7.2.5.1.1. Bakery
15.7.2.5.1.2. Dairy
15.7.2.5.1.3. Beverages
15.7.2.5.1.4. Others
15.7.2.5.2. Nutritional
and Dietary Supplements
15.7.2.5.3. Animal
Feed
15.7.2.5.4. Others
15.7.3. India
15.7.3.1. India
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
15.7.3.1.1. Lactobacillus
15.7.3.1.1.1. Lactobacillus
Acidophilus
15.7.3.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
15.7.3.1.1.3. Others
15.7.3.1.2. Bifidobacterium
15.7.3.1.2.1. Bifidobacterium
Bifidum
15.7.3.1.2.2. Bifidobacterium
Breve
15.7.3.1.2.3. Bifidobacterium
Animalis
15.7.3.1.2.4. Others
15.7.3.1.3. Saccharomyces
15.7.3.1.4. Streptococcus
15.7.3.1.5. Enterococcus
15.7.3.1.6. Escherichia
15.7.3.1.7. Bacillus
15.7.3.1.8. Others
15.7.3.2. India
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
15.7.3.2.1. Single
Stains
15.7.3.2.2. Multi
Strains
15.7.3.3. India
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
15.7.3.3.1. Powder
15.7.3.3.2. Capsules
15.7.3.3.3. Liquids
15.7.3.3.4. Lozenges
15.7.3.3.5. Others
15.7.3.4. India
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
15.7.3.4.1. Digestive
Health
15.7.3.4.2. Weight
Management
15.7.3.4.3. Immune
Health
15.7.3.4.4. Women’s
Health
15.7.3.4.5. Heart
Health
15.7.3.4.6. Oral
Health
15.7.3.4.7. Colon
Health
15.7.3.4.8. Bone
Health
15.7.3.4.9. GI
Tract Health
15.7.3.4.10. Others
15.7.3.5. India
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
15.7.3.5.1. Food
and Beverage
15.7.3.5.1.1. Bakery
15.7.3.5.1.2. Dairy
15.7.3.5.1.3. Beverages
15.7.3.5.1.4. Others
15.7.3.5.2. Nutritional
and Dietary Supplements
15.7.3.5.3. Animal
Feed
15.7.3.5.4. Others
15.7.4. New
Zealand
15.7.4.1. New
Zealand Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
15.7.4.1.1. Lactobacillus
15.7.4.1.1.1. Lactobacillus
Acidophilus
15.7.4.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
15.7.4.1.1.3. Others
15.7.4.1.2. Bifidobacterium
15.7.4.1.2.1. Bifidobacterium
Bifidum
15.7.4.1.2.2. Bifidobacterium
Breve
15.7.4.1.2.3. Bifidobacterium
Animalis
15.7.4.1.2.4. Others
15.7.4.1.3. Saccharomyces
15.7.4.1.4. Streptococcus
15.7.4.1.5. Enterococcus
15.7.4.1.6. Escherichia
15.7.4.1.7. Bacillus
15.7.4.1.8. Others
15.7.4.2. New
Zealand Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
15.7.4.2.1. Single
Stains
15.7.4.2.2. Multi
Strains
15.7.4.3. New
Zealand Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product
Form
15.7.4.3.1. Powder
15.7.4.3.2. Capsules
15.7.4.3.3. Liquids
15.7.4.3.4. Lozenges
15.7.4.3.5. Others
15.7.4.4. New
Zealand Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
15.7.4.4.1. Digestive
Health
15.7.4.4.2. Weight
Management
15.7.4.4.3. Immune
Health
15.7.4.4.4. Women’s
Health
15.7.4.4.5. Heart
Health
15.7.4.4.6. Oral
Health
15.7.4.4.7. Colon
Health
15.7.4.4.8. Bone
Health
15.7.4.4.9. GI
Tract Health
15.7.4.4.10. Others
15.7.4.5. New
Zealand Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
15.7.4.5.1. Food
and Beverage
15.7.4.5.1.1. Bakery
15.7.4.5.1.2. Dairy
15.7.4.5.1.3. Beverages
15.7.4.5.1.4. Others
15.7.4.5.2. Nutritional
and Dietary Supplements
15.7.4.5.3. Animal
Feed
15.7.4.5.4. Others
15.7.5. Australia
15.7.5.1. Australia
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
15.7.5.1.1. Lactobacillus
15.7.5.1.1.1. Lactobacillus
Acidophilus
15.7.5.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
15.7.5.1.1.3. Others
15.7.5.1.2. Bifidobacterium
15.7.5.1.2.1. Bifidobacterium
Bifidum
15.7.5.1.2.2. Bifidobacterium
Breve
15.7.5.1.2.3. Bifidobacterium
Animalis
15.7.5.1.2.4. Others
15.7.5.1.3. Saccharomyces
15.7.5.1.4. Streptococcus
15.7.5.1.5. Enterococcus
15.7.5.1.6. Escherichia
15.7.5.1.7. Bacillus
15.7.5.1.8. Others
15.7.5.2. Australia
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
15.7.5.2.1. Single
Stains
15.7.5.2.2. Multi
Strains
15.7.5.3. Australia
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
15.7.5.3.1. Powder
15.7.5.3.2. Capsules
15.7.5.3.3. Liquids
15.7.5.3.4. Lozenges
15.7.5.3.5. Others
15.7.5.4. Australia
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
15.7.5.4.1. Digestive
Health
15.7.5.4.2. Weight
Management
15.7.5.4.3. Immune
Health
15.7.5.4.4. Women’s
Health
15.7.5.4.5. Heart
Health
15.7.5.4.6. Oral
Health
15.7.5.4.7. Colon
Health
15.7.5.4.8. Bone
Health
15.7.5.4.9. GI
Tract Health
15.7.5.4.10. Others
15.7.5.5. Australia
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
15.7.5.5.1. Food
and Beverage
15.7.5.5.1.1. Bakery
15.7.5.5.1.2. Dairy
15.7.5.5.1.3. Beverages
15.7.5.5.1.4. Others
15.7.5.5.2. Nutritional
and Dietary Supplements
15.7.5.5.3. Animal
Feed
15.7.5.5.4. Others
15.7.6. South
Korea
15.7.6.1. South
Korea Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
15.7.6.1.1. Lactobacillus
15.7.6.1.1.1. Lactobacillus
Acidophilus
15.7.6.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
15.7.6.1.1.3. Others
15.7.6.1.2. Bifidobacterium
15.7.6.1.2.1. Bifidobacterium
Bifidum
15.7.6.1.2.2. Bifidobacterium
Breve
15.7.6.1.2.3. Bifidobacterium
Animalis
15.7.6.1.2.4. Others
15.7.6.1.3. Saccharomyces
15.7.6.1.4. Streptococcus
15.7.6.1.5. Enterococcus
15.7.6.1.6. Escherichia
15.7.6.1.7. Bacillus
15.7.6.1.8. Others
15.7.6.2. South
Korea Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
15.7.6.2.1. Single
Stains
15.7.6.2.2. Multi
Strains
15.7.6.3. South
Korea Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
15.7.6.3.1. Powder
15.7.6.3.2. Capsules
15.7.6.3.3. Liquids
15.7.6.3.4. Lozenges
15.7.6.3.5. Others
15.7.6.4. South
Korea Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
15.7.6.4.1. Digestive
Health
15.7.6.4.2. Weight
Management
15.7.6.4.3. Immune
Health
15.7.6.4.4. Women’s
Health
15.7.6.4.5. Heart
Health
15.7.6.4.6. Oral
Health
15.7.6.4.7. Colon
Health
15.7.6.4.8. Bone
Health
15.7.6.4.9. GI
Tract Health
15.7.6.4.10. Others
15.7.6.5. South
Korea Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
15.7.6.5.1. Food
and Beverage
15.7.6.5.1.1. Bakery
15.7.6.5.1.2. Dairy
15.7.6.5.1.3. Beverages
15.7.6.5.1.4. Others
15.7.6.5.2. Nutritional
and Dietary Supplements
15.7.6.5.3. Animal
Feed
15.7.6.5.4. Others
15.7.7. Southeast
Asia
15.7.7.1. Southeast
Asia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
15.7.7.1.1. Lactobacillus
15.7.7.1.1.1. Lactobacillus
Acidophilus
15.7.7.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
15.7.7.1.1.3. Others
15.7.7.1.2. Bifidobacterium
15.7.7.1.2.1. Bifidobacterium
Bifidum
15.7.7.1.2.2. Bifidobacterium
Breve
15.7.7.1.2.3. Bifidobacterium
Animalis
15.7.7.1.2.4. Others
15.7.7.1.3. Saccharomyces
15.7.7.1.4. Streptococcus
15.7.7.1.5. Enterococcus
15.7.7.1.6. Escherichia
15.7.7.1.7. Bacillus
15.7.7.1.8. Others
15.7.7.2. Southeast
Asia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
15.7.7.2.1. Single
Stains
15.7.7.2.2. Multi
Strains
15.7.7.3. Southeast
Asia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
15.7.7.3.1. Powder
15.7.7.3.2. Capsules
15.7.7.3.3. Liquids
15.7.7.3.4. Lozenges
15.7.7.3.5. Others
15.7.7.4. Southeast
Asia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
15.7.7.4.1. Digestive
Health
15.7.7.4.2. Weight
Management
15.7.7.4.3. Immune
Health
15.7.7.4.4. Women’s
Health
15.7.7.4.5. Heart
Health
15.7.7.4.6. Oral
Health
15.7.7.4.7. Colon
Health
15.7.7.4.8. Bone
Health
15.7.7.4.9. GI
Tract Health
15.7.7.4.10. Others
15.7.7.5. Southeast
Asia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
15.7.7.5.1. Food
and Beverage
15.7.7.5.1.1. Bakery
15.7.7.5.1.2. Dairy
15.7.7.5.1.3. Beverages
15.7.7.5.1.4. Others
15.7.7.5.2. Nutritional
and Dietary Supplements
15.7.7.5.3. Animal
Feed
15.7.7.5.4. Others
15.7.7.6. Southeast
Asia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest
of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest
of Asia Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Type
15.7.8.1.1. Lactobacillus
15.7.8.1.1.1. Lactobacillus
Acidophilus
15.7.8.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
15.7.8.1.1.3. Others
15.7.8.1.2. Bifidobacterium
15.7.8.1.2.1. Bifidobacterium
Bifidum
15.7.8.1.2.2. Bifidobacterium
Breve
15.7.8.1.2.3. Bifidobacterium
Animalis
15.7.8.1.2.4. Others
15.7.8.1.3. Saccharomyces
15.7.8.1.4. Streptococcus
15.7.8.1.5. Enterococcus
15.7.8.1.6. Escherichia
15.7.8.1.7. Bacillus
15.7.8.1.8. Others
15.7.8.2. Rest
of Asia Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Formulation
15.7.8.2.1. Single
Stains
15.7.8.2.2. Multi
Strains
15.7.8.3. Rest
of Asia Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Product Form
15.7.8.3.1. Powder
15.7.8.3.2. Capsules
15.7.8.3.3. Liquids
15.7.8.3.4. Lozenges
15.7.8.3.5. Others
15.7.8.4. Rest
of Asia Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Health Indication
15.7.8.4.1. Digestive
Health
15.7.8.4.2. Weight
Management
15.7.8.4.3. Immune
Health
15.7.8.4.4. Women’s
Health
15.7.8.4.5. Heart
Health
15.7.8.4.6. Oral
Health
15.7.8.4.7. Colon
Health
15.7.8.4.8. Bone
Health
15.7.8.4.9. GI
Tract Health
15.7.8.4.10. Others
15.7.8.5. Rest
of Asia Pacific Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.8.5.1. Food
and Beverage
15.7.8.5.1.1. Bakery
15.7.8.5.1.2. Dairy
15.7.8.5.1.3. Beverages
15.7.8.5.1.4. Others
15.7.8.5.2. Nutritional
and Dietary Supplements
15.7.8.5.3. Animal
Feed
15.7.8.5.4. Others
15.8. Key
Segment for Channeling Investments
15.8.1. By
Country
15.8.2. By Type
15.8.3. By
Formulation
15.8.4. By
Product Form
15.8.5. By
Health Indication
15.8.6. By
Application
16. Middle
East and Africa Probiotic Strains Market Analysis and Forecasts, 2020 - 2028
16.1. Overview
16.1.1. Middle
East and Africa Probiotic Strains Market Revenue (US$ Mn)
16.2. Middle
East and Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Type
16.2.1. Lactobacillus
16.2.1.1. Lactobacillus
Acidophilus
16.2.1.2. Lactobacillus
Rhamnosus GG (LGG)
16.2.1.3. Others
16.2.2. Bifidobacterium
16.2.2.1. Bifidobacterium
Bifidum
16.2.2.2. Bifidobacterium
Breve
16.2.2.3. Bifidobacterium
Animalis
16.2.2.4. Others
16.2.3. Saccharomyces
16.2.4. Streptococcus
16.2.5. Enterococcus
16.2.6. Escherichia
16.2.7. Bacillus
16.2.8. Others
16.3. Middle
East and Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Formulation
16.3.1. Single
Stains
16.3.2. Multi
Strains
16.4. Middle
East and Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Product Form
16.4.1. Powder
16.4.2. Capsules
16.4.3. Liquids
16.4.4. Lozenges
16.4.5. Others
16.5. Middle
East and Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Health Indication
16.5.1. Digestive
Health
16.5.2. Weight
Management
16.5.3. Immune
Health
16.5.4. Women’s
Health
16.5.5. Heart
Health
16.5.6. Oral
Health
16.5.7. Colon
Health
16.5.8. Bone
Health
16.5.9. GI
Tract Health
16.5.10. Others
16.6. Middle
East and Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Application
16.6.1. Food
and Beverage
16.6.1.1. Bakery
16.6.1.2. Dairy
16.6.1.3. Beverages
16.6.1.4. Others
16.6.2. Nutritional
and Dietary Supplements
16.6.3. Animal
Feed
16.6.4. Others
16.7. Middle
East and Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Country
16.7.1. Saudi
Arabia
16.7.1.1. Saudi
Arabia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
16.7.1.1.1. Lactobacillus
16.7.1.1.1.1. Lactobacillus
Acidophilus
16.7.1.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
16.7.1.1.1.3. Others
16.7.1.1.2. Bifidobacterium
16.7.1.1.2.1. Bifidobacterium
Bifidum
16.7.1.1.2.2. Bifidobacterium
Breve
16.7.1.1.2.3. Bifidobacterium
Animalis
16.7.1.1.2.4. Others
16.7.1.1.3. Saccharomyces
16.7.1.1.4. Streptococcus
16.7.1.1.5. Enterococcus
16.7.1.1.6. Escherichia
16.7.1.1.7. Bacillus
16.7.1.1.8. Others
16.7.1.2. Saudi
Arabia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
16.7.1.2.1. Single
Stains
16.7.1.2.2. Multi
Strains
16.7.1.3. Saudi
Arabia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
16.7.1.3.1. Powder
16.7.1.3.2. Capsules
16.7.1.3.3. Liquids
16.7.1.3.4. Lozenges
16.7.1.3.5. Others
16.7.1.4. Saudi
Arabia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
16.7.1.4.1. Digestive
Health
16.7.1.4.2. Weight
Management
16.7.1.4.3. Immune
Health
16.7.1.4.4. Women’s
Health
16.7.1.4.5. Heart
Health
16.7.1.4.6. Oral
Health
16.7.1.4.7. Colon
Health
16.7.1.4.8. Bone
Health
16.7.1.4.9. GI
Tract Health
16.7.1.4.10. Others
16.7.1.5. Saudi
Arabia Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
16.7.1.5.1. Food
and Beverage
16.7.1.5.1.1. Bakery
16.7.1.5.1.2. Dairy
16.7.1.5.1.3. Beverages
16.7.1.5.1.4. Others
16.7.1.5.2. Nutritional
and Dietary Supplements
16.7.1.5.3. Animal
Feed
16.7.1.5.4. Others
16.7.2. UAE
16.7.2.1. UAE
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
16.7.2.1.1. Lactobacillus
16.7.2.1.1.1. Lactobacillus
Acidophilus
16.7.2.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
16.7.2.1.1.3. Others
16.7.2.1.2. Bifidobacterium
16.7.2.1.2.1. Bifidobacterium
Bifidum
16.7.2.1.2.2. Bifidobacterium
Breve
16.7.2.1.2.3. Bifidobacterium
Animalis
16.7.2.1.2.4. Others
16.7.2.1.3. Saccharomyces
16.7.2.1.4. Streptococcus
16.7.2.1.5. Enterococcus
16.7.2.1.6. Escherichia
16.7.2.1.7. Bacillus
16.7.2.1.8. Others
16.7.2.2. UAE
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
16.7.2.2.1. Single
Stains
16.7.2.2.2. Multi
Strains
16.7.2.3. UAE Probiotic
Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
16.7.2.3.1. Powder
16.7.2.3.2. Capsules
16.7.2.3.3. Liquids
16.7.2.3.4. Lozenges
16.7.2.3.5. Others
16.7.2.4. UAE
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
16.7.2.4.1. Digestive
Health
16.7.2.4.2. Weight
Management
16.7.2.4.3. Immune
Health
16.7.2.4.4. Women’s
Health
16.7.2.4.5. Heart
Health
16.7.2.4.6. Oral
Health
16.7.2.4.7. Colon
Health
16.7.2.4.8. Bone
Health
16.7.2.4.9. GI
Tract Health
16.7.2.4.10. Others
16.7.2.5. UAE
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
16.7.2.5.1. Food
and Beverage
16.7.2.5.1.1. Bakery
16.7.2.5.1.2. Dairy
16.7.2.5.1.3. Beverages
16.7.2.5.1.4. Others
16.7.2.5.2. Nutritional
and Dietary Supplements
16.7.2.5.3. Animal
Feed
16.7.2.5.4. Others
16.7.3. Egypt
16.7.3.1. Egypt
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
16.7.3.1.1. Lactobacillus
16.7.3.1.1.1. Lactobacillus
Acidophilus
16.7.3.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
16.7.3.1.1.3. Others
16.7.3.1.2. Bifidobacterium
16.7.3.1.2.1. Bifidobacterium
Bifidum
16.7.3.1.2.2. Bifidobacterium
Breve
16.7.3.1.2.3. Bifidobacterium
Animalis
16.7.3.1.2.4. Others
16.7.3.1.3. Saccharomyces
16.7.3.1.4. Streptococcus
16.7.3.1.5. Enterococcus
16.7.3.1.6. Escherichia
16.7.3.1.7. Bacillus
16.7.3.1.8. Others
16.7.3.2. Egypt
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
16.7.3.2.1. Single
Stains
16.7.3.2.2. Multi
Strains
16.7.3.3. Egypt
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
16.7.3.3.1. Powder
16.7.3.3.2. Capsules
16.7.3.3.3. Liquids
16.7.3.3.4. Lozenges
16.7.3.3.5. Others
16.7.3.4. Egypt
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
16.7.3.4.1. Digestive
Health
16.7.3.4.2. Weight
Management
16.7.3.4.3. Immune
Health
16.7.3.4.4. Women’s
Health
16.7.3.4.5. Heart
Health
16.7.3.4.6. Oral
Health
16.7.3.4.7. Colon
Health
16.7.3.4.8. Bone
Health
16.7.3.4.9. GI
Tract Health
16.7.3.4.10. Others
16.7.3.5. Egypt
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
16.7.3.5.1. Food
and Beverage
16.7.3.5.1.1. Bakery
16.7.3.5.1.2. Dairy
16.7.3.5.1.3. Beverages
16.7.3.5.1.4. Others
16.7.3.5.2. Nutritional
and Dietary Supplements
16.7.3.5.3. Animal
Feed
16.7.3.5.4. Others
16.7.4. Kuwait
16.7.4.1. Kuwait
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
16.7.4.1.1. Lactobacillus
16.7.4.1.1.1. Lactobacillus
Acidophilus
16.7.4.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
16.7.4.1.1.3. Others
16.7.4.1.2. Bifidobacterium
16.7.4.1.2.1. Bifidobacterium
Bifidum
16.7.4.1.2.2. Bifidobacterium
Breve
16.7.4.1.2.3. Bifidobacterium
Animalis
16.7.4.1.2.4. Others
16.7.4.1.3. Saccharomyces
16.7.4.1.4. Streptococcus
16.7.4.1.5. Enterococcus
16.7.4.1.6. Escherichia
16.7.4.1.7. Bacillus
16.7.4.1.8. Others
16.7.4.2. Kuwait
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
16.7.4.2.1. Single
Stains
16.7.4.2.2. Multi
Strains
16.7.4.3. Kuwait
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
16.7.4.3.1. Powder
16.7.4.3.2. Capsules
16.7.4.3.3. Liquids
16.7.4.3.4. Lozenges
16.7.4.3.5. Others
16.7.4.4. Kuwait
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
16.7.4.4.1. Digestive
Health
16.7.4.4.2. Weight
Management
16.7.4.4.3. Immune
Health
16.7.4.4.4. Women’s
Health
16.7.4.4.5. Heart
Health
16.7.4.4.6. Oral
Health
16.7.4.4.7. Colon
Health
16.7.4.4.8. Bone
Health
16.7.4.4.9. GI
Tract Health
16.7.4.4.10. Others
16.7.4.5. Kuwait
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
16.7.4.5.1. Food
and Beverage
16.7.4.5.1.1. Bakery
16.7.4.5.1.2. Dairy
16.7.4.5.1.3. Beverages
16.7.4.5.1.4. Others
16.7.4.5.2. Nutritional
and Dietary Supplements
16.7.4.5.3. Animal
Feed
16.7.4.5.4. Others
16.7.5. South
Africa
16.7.5.1. South
Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
16.7.5.1.1. Lactobacillus
16.7.5.1.1.1. Lactobacillus
Acidophilus
16.7.5.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
16.7.5.1.1.3. Others
16.7.5.1.2. Bifidobacterium
16.7.5.1.2.1. Bifidobacterium
Bifidum
16.7.5.1.2.2. Bifidobacterium
Breve
16.7.5.1.2.3. Bifidobacterium
Animalis
16.7.5.1.2.4. Others
16.7.5.1.3. Saccharomyces
16.7.5.1.4. Streptococcus
16.7.5.1.5. Enterococcus
16.7.5.1.6. Escherichia
16.7.5.1.7. Bacillus
16.7.5.1.8. Others
16.7.5.2. South
Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
16.7.5.2.1. Single
Stains
16.7.5.2.2. Multi
Strains
16.7.5.3. South
Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
16.7.5.3.1. Powder
16.7.5.3.2. Capsules
16.7.5.3.3. Liquids
16.7.5.3.4. Lozenges
16.7.5.3.5. Others
16.7.5.4. South
Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
16.7.5.4.1. Digestive
Health
16.7.5.4.2. Weight
Management
16.7.5.4.3. Immune
Health
16.7.5.4.4. Women’s
Health
16.7.5.4.5. Heart
Health
16.7.5.4.6. Oral
Health
16.7.5.4.7. Colon
Health
16.7.5.4.8. Bone
Health
16.7.5.4.9. GI
Tract Health
16.7.5.4.10. Others
16.7.5.5. South
Africa Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
16.7.5.5.1. Food
and Beverage
16.7.5.5.1.1. Bakery
16.7.5.5.1.2. Dairy
16.7.5.5.1.3. Beverages
16.7.5.5.1.4. Others
16.7.5.5.2. Nutritional
and Dietary Supplements
16.7.5.5.3. Animal
Feed
16.7.5.5.4. Others
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest
of Middle East & Africa Probiotic Strains Market Revenue (US$ Mn) and
Forecasts, By Type
16.7.6.1.1. Lactobacillus
16.7.6.1.1.1. Lactobacillus
Acidophilus
16.7.6.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
16.7.6.1.1.3. Others
16.7.6.1.2. Bifidobacterium
16.7.6.1.2.1. Bifidobacterium
Bifidum
16.7.6.1.2.2. Bifidobacterium
Breve
16.7.6.1.2.3. Bifidobacterium
Animalis
16.7.6.1.2.4. Others
16.7.6.1.3. Saccharomyces
16.7.6.1.4. Streptococcus
16.7.6.1.5. Enterococcus
16.7.6.1.6. Escherichia
16.7.6.1.7. Bacillus
16.7.6.1.8. Others
16.7.6.2. Rest
of Middle East & Africa Probiotic Strains Market Revenue (US$ Mn) and
Forecasts, By Formulation
16.7.6.2.1. Single
Stains
16.7.6.2.2. Multi
Strains
16.7.6.3. Rest
of Middle East & Africa Probiotic Strains Market Revenue (US$ Mn) and
Forecasts, By Product Form
16.7.6.3.1. Powder
16.7.6.3.2. Capsules
16.7.6.3.3. Liquids
16.7.6.3.4. Lozenges
16.7.6.3.5. Others
16.7.6.4. Rest
of Middle East & Africa Probiotic Strains Market Revenue (US$ Mn) and
Forecasts, By Health Indication
16.7.6.4.1. Digestive
Health
16.7.6.4.2. Weight
Management
16.7.6.4.3. Immune
Health
16.7.6.4.4. Women’s
Health
16.7.6.4.5. Heart
Health
16.7.6.4.6. Oral
Health
16.7.6.4.7. Colon
Health
16.7.6.4.8. Bone
Health
16.7.6.4.9. GI
Tract Health
16.7.6.4.10. Others
16.7.6.5. Rest
of Middle East & Africa Probiotic Strains Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.6.5.1. Food
and Beverage
16.7.6.5.1.1. Bakery
16.7.6.5.1.2. Dairy
16.7.6.5.1.3. Beverages
16.7.6.5.1.4. Others
16.7.6.5.2. Nutritional
and Dietary Supplements
16.7.6.5.3. Animal
Feed
16.7.6.5.4. Others
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By Type
16.8.3. By
Formulation
16.8.4. By
Product Form
16.8.5. By
Health Indication
16.8.6. By
Application
17. Latin
America Probiotic Strains Market Analysis and Forecasts, 2020 - 2028
17.1. Overview
17.1.1. Latin
America Probiotic Strains Market Revenue (US$ Mn)
17.2. Latin
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
17.2.1. Lactobacillus
17.2.1.1. Lactobacillus
Acidophilus
17.2.1.2. Lactobacillus
Rhamnosus GG (LGG)
17.2.1.3. Others
17.2.2. Bifidobacterium
17.2.2.1. Bifidobacterium
Bifidum
17.2.2.2. Bifidobacterium
Breve
17.2.2.3. Bifidobacterium
Animalis
17.2.2.4. Others
17.2.3. Saccharomyces
17.2.4. Streptococcus
17.2.5. Enterococcus
17.2.6. Escherichia
17.2.7. Bacillus
17.2.8. Others
17.3. Latin
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
17.3.1. Single
Stains
17.3.2. Multi
Strains
17.4. Latin
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product
Form
17.4.1. Powder
17.4.2. Capsules
17.4.3. Liquids
17.4.4. Lozenges
17.4.5. Others
17.5. Latin
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health
Indication
17.5.1. Digestive
Health
17.5.2. Weight
Management
17.5.3. Immune
Health
17.5.4. Women’s
Health
17.5.5. Heart
Health
17.5.6. Oral
Health
17.5.7. Colon
Health
17.5.8. Bone
Health
17.5.9. GI
Tract Health
17.5.10. Others
17.6. Latin
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
17.6.1. Food
and Beverage
17.6.1.1. Bakery
17.6.1.2. Dairy
17.6.1.3. Beverages
17.6.1.4. Others
17.6.2. Nutritional
and Dietary Supplements
17.6.3. Animal
Feed
17.6.4. Others
17.7. Latin
America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1. Brazil
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
17.7.1.1.1. Lactobacillus
17.7.1.1.1.1. Lactobacillus
Acidophilus
17.7.1.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
17.7.1.1.1.3. Others
17.7.1.1.2. Bifidobacterium
17.7.1.1.2.1. Bifidobacterium
Bifidum
17.7.1.1.2.2. Bifidobacterium
Breve
17.7.1.1.2.3. Bifidobacterium
Animalis
17.7.1.1.2.4. Others
17.7.1.1.3. Saccharomyces
17.7.1.1.4. Streptococcus
17.7.1.1.5. Enterococcus
17.7.1.1.6. Escherichia
17.7.1.1.7. Bacillus
17.7.1.1.8. Others
17.7.1.2. Brazil
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
17.7.1.2.1. Single
Stains
17.7.1.2.2. Multi
Strains
17.7.1.3. Brazil
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
17.7.1.3.1. Powder
17.7.1.3.2. Capsules
17.7.1.3.3. Liquids
17.7.1.3.4. Lozenges
17.7.1.3.5. Others
17.7.1.4. Brazil
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
17.7.1.4.1. Digestive
Health
17.7.1.4.2. Weight
Management
17.7.1.4.3. Immune
Health
17.7.1.4.4. Women’s
Health
17.7.1.4.5. Heart
Health
17.7.1.4.6. Oral
Health
17.7.1.4.7. Colon
Health
17.7.1.4.8. Bone
Health
17.7.1.4.9. GI
Tract Health
17.7.1.4.10. Others
17.7.1.5. Brazil
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
17.7.1.5.1. Food
and Beverage
17.7.1.5.1.1. Bakery
17.7.1.5.1.2. Dairy
17.7.1.5.1.3. Beverages
17.7.1.5.1.4. Others
17.7.1.5.2. Nutritional
and Dietary Supplements
17.7.1.5.3. Animal
Feed
17.7.1.5.4. Others
17.7.2. Argentina
17.7.2.1. Argentina
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Type
17.7.2.1.1. Lactobacillus
17.7.2.1.1.1. Lactobacillus
Acidophilus
17.7.2.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
17.7.2.1.1.3. Others
17.7.2.1.2. Bifidobacterium
17.7.2.1.2.1. Bifidobacterium
Bifidum
17.7.2.1.2.2. Bifidobacterium
Breve
17.7.2.1.2.3. Bifidobacterium
Animalis
17.7.2.1.2.4. Others
17.7.2.1.3. Saccharomyces
17.7.2.1.4. Streptococcus
17.7.2.1.5. Enterococcus
17.7.2.1.6. Escherichia
17.7.2.1.7. Bacillus
17.7.2.1.8. Others
17.7.2.2. Argentina
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Formulation
17.7.2.2.1. Single
Stains
17.7.2.2.2. Multi
Strains
17.7.2.3. Argentina
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Product Form
17.7.2.3.1. Powder
17.7.2.3.2. Capsules
17.7.2.3.3. Liquids
17.7.2.3.4. Lozenges
17.7.2.3.5. Others
17.7.2.4. Argentina
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Health Indication
17.7.2.4.1. Digestive
Health
17.7.2.4.2. Weight
Management
17.7.2.4.3. Immune
Health
17.7.2.4.4. Women’s
Health
17.7.2.4.5. Heart
Health
17.7.2.4.6. Oral
Health
17.7.2.4.7. Colon
Health
17.7.2.4.8. Bone
Health
17.7.2.4.9. GI
Tract Health
17.7.2.4.10. Others
17.7.2.5. Argentina
Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By Application
17.7.2.5.1. Food
and Beverage
17.7.2.5.1.1. Bakery
17.7.2.5.1.2. Dairy
17.7.2.5.1.3. Beverages
17.7.2.5.1.4. Others
17.7.2.5.2. Nutritional
and Dietary Supplements
17.7.2.5.3. Animal
Feed
17.7.2.5.4. Others
17.7.3. Rest of
Latin America
17.7.3.1. Rest
of Latin America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Type
17.7.3.1.1. Lactobacillus
17.7.3.1.1.1. Lactobacillus
Acidophilus
17.7.3.1.1.2. Lactobacillus
Rhamnosus GG (LGG)
17.7.3.1.1.3. Others
17.7.3.1.2. Bifidobacterium
17.7.3.1.2.1. Bifidobacterium
Bifidum
17.7.3.1.2.2. Bifidobacterium
Breve
17.7.3.1.2.3. Bifidobacterium
Animalis
17.7.3.1.2.4. Others
17.7.3.1.3. Saccharomyces
17.7.3.1.4. Streptococcus
17.7.3.1.5. Enterococcus
17.7.3.1.6. Escherichia
17.7.3.1.7. Bacillus
17.7.3.1.8. Others
17.7.3.2. Rest
of Latin America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Formulation
17.7.3.2.1. Single
Stains
17.7.3.2.2. Multi
Strains
17.7.3.3. Rest
of Latin America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Product Form
17.7.3.3.1. Powder
17.7.3.3.2. Capsules
17.7.3.3.3. Liquids
17.7.3.3.4. Lozenges
17.7.3.3.5. Others
17.7.3.4. Rest
of Latin America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Health Indication
17.7.3.4.1. Digestive
Health
17.7.3.4.2. Weight
Management
17.7.3.4.3. Immune
Health
17.7.3.4.4. Women’s
Health
17.7.3.4.5. Heart
Health
17.7.3.4.6. Oral
Health
17.7.3.4.7. Colon
Health
17.7.3.4.8. Bone
Health
17.7.3.4.9. GI
Tract Health
17.7.3.4.10. Others
17.7.3.5. Rest
of Latin America Probiotic Strains Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.3.5.1. Food
and Beverage
17.7.3.5.1.1. Bakery
17.7.3.5.1.2. Dairy
17.7.3.5.1.3. Beverages
17.7.3.5.1.4. Others
17.7.3.5.2. Nutritional
and Dietary Supplements
17.7.3.5.3. Animal
Feed
17.7.3.5.4. Others
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By Type
17.8.3. By
Formulation
17.8.4. By
Product Form
17.8.5. By
Health Indication
17.8.6. By Application
18. Competitive
Benchmarking
18.1. Market
Share Analysis, 2019
18.2. Global
Presence and Growth Strategies
18.2.1. Mergers
and Acquisitions
18.2.2. Product
Launches
18.2.3. Investments
Trends
18.2.4. R&D
Initiatives
19. Player
Profiles
19.1. Aumgene
Biosciences
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business
Strategies
19.2. BioGaia
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT
Analysis
19.2.7. Business
Strategies
19.3. BLIS
Technologies.
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT
Analysis
19.3.7. Business
Strategies
19.4. Cerbios-Pharma
SA
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key
Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. Chr.
Hansen Holding A/S
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. DSM
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business
Strategies
19.7. DuPont
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key
Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business
Strategies
19.8. Essum AB
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT
Analysis
19.8.7. Business
Strategies
19.9. Kerry
Inc.
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business
Strategies
19.10. Lab4
19.10.1. Company
Details
19.10.2. Company
Overview
19.10.3. Product
Offerings
19.10.4. Key
Developments
19.10.5. Financial
Analysis
19.10.6. SWOT
Analysis
19.10.7. Business
Strategies
19.11. Lallemand
Inc.
19.11.1. Company
Details
19.11.2. Company
Overview
19.11.3. Product
Offerings
19.11.4. Key
Developments
19.11.5. Financial
Analysis
19.11.6. SWOT
Analysis
19.11.7. Business
Strategies
19.12. Phileo
by Lesaffre
19.12.1. Company
Details
19.12.2. Company
Overview
19.12.3. Product
Offerings
19.12.4. Key
Developments
19.12.5. Financial
Analysis
19.12.6. SWOT Analysis
19.12.7. Business
Strategies
19.13. Probi
19.13.1. Company
Details
19.13.2. Company
Overview
19.13.3. Product
Offerings
19.13.4. Key
Developments
19.13.5. Financial
Analysis
19.13.6. SWOT
Analysis
19.13.7. Business
Strategies
19.14. Protexin
19.14.1. Company
Details
19.14.2. Company
Overview
19.14.3. Product
Offerings
19.14.4. Key
Developments
19.14.5. Financial
Analysis
19.14.6. SWOT
Analysis
19.14.7. Business
Strategies
19.15. Unique
Biotech
19.15.1. Company
Details
19.15.2. Company
Overview
19.15.3. Product
Offerings
19.15.4. Key
Developments
19.15.5. Financial
Analysis
19.15.6. SWOT
Analysis
19.15.7. Business Strategies
19.16. Other
Industry Participants
20. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.